05.02.2014 Views

fema trailer mdl no. 1873 formaldehyde p - US District Court ...

fema trailer mdl no. 1873 formaldehyde p - US District Court ...

fema trailer mdl no. 1873 formaldehyde p - US District Court ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

UNITED STATES DISTRICT COURT<br />

EASTERN DISTRICT OF LOUISIANA<br />

NEW ORLEANS DIVISION<br />

IN RE: FEMA TRAILER MDL NO. <strong>1873</strong><br />

FORMALDEHYDE<br />

PRODUCT LIABILITY LITIGATION<br />

SECTION “N-5"<br />

THIS DOCUMENT IS RELATED TO:<br />

Lyndon Wright v. Forest River, Inc., et al.<br />

Case No. 09-2977 (E.D. La.)<br />

JUDGE ENGELHARDT<br />

MAG. JUDGE CHASEZ<br />

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *<br />

PLAINTIFF’S EXHIBIT LIST<br />

NOW INTO COURT, through undersigned counsel, comes Plaintiff, Lyndon Wright,<br />

pursuant to this Ho<strong>no</strong>rable <strong>Court</strong>’s August 2009 Trial Scheduling Order, who hereby submits the<br />

following Exhibit List in connection with the above-captioned matter, to be supplemented by<br />

ongoing production, depositions and discovery:<br />

Exhibit<br />

ID<br />

Plaintiff<br />

’s<br />

Exhibits<br />

Government<br />

al Agency<br />

Reports and<br />

Studies<br />

1. CDC Summary and Interim Report:<br />

VOC and Aldehyde Emissions in Four<br />

FEMA Temporary Housing Unites –<br />

Indoor Environment Department,<br />

Lawrence Berkeley National Laboratory,<br />

8 May, 2008<br />

Category: Exhibit Description: Bates Range:<br />

1<br />

PSC002113 –<br />

PSC002166<br />

2. U.S. Department of Health and Human PSC002167 –


Services and CDC Presentation Titled<br />

“Formaldehyde Levels in Occupied<br />

FEMA-supplied Temporary Housing<br />

Units (THUs) in LA and MS, Winter<br />

2007-2008”<br />

3. CDC Interim findings on Formaldehyde<br />

Levels in FEMA-Supplied Travel<br />

Trailers, Park Models, and Mobile<br />

Homes-February 29, 2008<br />

4. Agency for Toxic Substances and<br />

Disease Registry (ATSDR) “Health<br />

Consultations, Formaldehyde Sampling<br />

at FEMA Temporary Housing Units,<br />

Baton Rouge, Louisiana, February 1,<br />

2007<br />

5. ATSDR October 2007 “An Update and<br />

Revision of ATSDR’s February 2007<br />

Health Consultation: Formaldehyde<br />

Sampling of FEMA Temporary-Housing<br />

Trailers Baton Rouge, Louisiana,<br />

September –October 2006”<br />

6. Statement of Harvey E. Johnson, Jr.,<br />

Acting Deputy Administrator and Chief<br />

Operating Officer for FEMA before the<br />

U.S. Senate Subcommittee on State,<br />

Local, and Private Sector Preparedness<br />

and Integration, March 4, 2008<br />

7. Statement of R. David Paulison, FEMA<br />

Administrator, before the U.S. House of<br />

Representatives Committee on Oversight<br />

and Government Reform, July 19, 2007<br />

8. “Formaldehyde Exposure in Homes: A<br />

Reference for State Officials to Use in<br />

Decision-Making” published in March<br />

2008 by the DHHS, CDC, DHS, FEMA<br />

and the EPA<br />

9. U.S. EPA “Indoor Air Quality” Basic<br />

Information for Formaldehyde-Last<br />

updated November 14, 2007<br />

10. “Formaldehyde Levels in FEMA-<br />

Supplied Trailers-Early Findings from<br />

the Centers for Disease Control and<br />

Prevention”<br />

2<br />

PSC002181<br />

PSC002182 –<br />

PSC002202<br />

PSC002264 –<br />

PSC002277<br />

PSC002278 –<br />

PSC002318<br />

PSC003188 –<br />

PSC003198<br />

PSC003199 –<br />

PSC003207<br />

PSC003208 –<br />

PSC003213<br />

PSC003214 –<br />

PSC003217<br />

PSC003218 –<br />

PSC003219<br />

11. ASTM Standard Test Method for PSC021571 –


Determining<br />

Formaldehyde PSC021582<br />

concentrations in Air and Emission<br />

Rates in Wood Products Using a Large<br />

Chamber (2002)<br />

12. Indoor Air Quality and Health in FEMA PSC021583 –<br />

Temporary Housing for Trailer PSC021584<br />

Residents prepared by CDC<br />

13. Trailer Manufacturers and Elevated PSC024251 –<br />

Formaldehyde Levels Majority Staff PSC024277<br />

Analysis, Committee on Oversight and<br />

government Reform, U.S. House of<br />

Representatives dated on July 9, 2008<br />

14. ASHRAE Handbook, 2007: HVAC<br />

Applications, Chapter One: Residences<br />

DUB002101 –<br />

DUB002107<br />

15. Department of Homeland Security, PSC025938 –<br />

Office of Inspector General: FEMA’s PSC026022<br />

Response to Formaldehyde in Trailers<br />

dated June, 2009<br />

16. Majority Staff Report Subcommittee on<br />

Investigations & Oversight – Committee<br />

PSC002070 –<br />

PSC002112<br />

on Science & Tech<strong>no</strong>logy U.S. House of<br />

Representatives, September 2008,<br />

“Toxic Trailers-Toxic Lethargy: How<br />

the Centers for Disease Control and<br />

Prevention Has Failed to Protect the<br />

Public Health”<br />

17. CDC Interim on CDC Study for<br />

Formaldehyde<br />

LWFR-EXP11-000956-<br />

LWFR-EXP11-000976<br />

18. CDC Final Reports on CDC Study for LWFR-EXP11-000889-<br />

Formaldehyde<br />

LWFR-EXP11-000949<br />

19. Lawrence Berkeley Nation Labs report LWFR-EXP11-001569-<br />

on VOCs in Four Trailers<br />

LWFR-EXP11-001629<br />

20. ATSDR Toxicological Profile for LWFR-EXP11-000294-<br />

Formaldehyde<br />

LWFR-EXP11-000761<br />

21. IARC Mo<strong>no</strong>graphs 2004/2009 To be supplemented<br />

22. ASTDR, Minimal Risk Levels (MRLs) To be supplemented<br />

for Hazardous Substances, 2007<br />

http://www.astdr.cdc.gov/mrls/index.htm<br />

l<br />

23. CDC THU Formaldehyde Test Protocol LWFR-EXP 11-000977 –<br />

LWFR-EXP 11-001012<br />

24. NIOSH, EPA, OSHA, etc. re: To be supplemented<br />

Formaldehyde levels<br />

25. CDC, Final Report on Formaldehyde LWFR-EXP 11-00889 –<br />

3


Levels in FEMA-Supplied Travel LWFR-EXP 11-00949<br />

Trailers, Park Models, and Mobile<br />

Homes; Conclusions; 2008,<br />

http://www.cdc.gov/nceh/ehhe/<strong>trailer</strong>stu<br />

dy/residents.htm<br />

Standards,<br />

Regulations,<br />

and Statutes<br />

25 24 C.F.R. § 3280.309, Health Notice on PSC003147<br />

<strong>formaldehyde</strong> emissions Current through<br />

November 6, 2008<br />

26. 24 C.F.R. Parts 3280 and 3285 LWFR-EXP5-000457-<br />

27. §3280.309 – 24 CFR Ch. XX, Health<br />

Notice on Formaldehyde emissions (4-1-<br />

07)<br />

28. ATSDR Formaldehyde Minimal Risk<br />

Levels and Worksheets – Appendix A<br />

29. U.S. Department of Housing and Urban<br />

Development Rules and Regulations<br />

regarding Formaldehyde, 49 FR 31996<br />

30. California air Resources Board’s<br />

(CARB) Standards<br />

31. Occupational Safety and Health<br />

Administration’s (OSHA) Standards for<br />

Formaldehyde<br />

32. American Conference of Governmental<br />

Industrial Hygienists’ (ACGIH)<br />

Standards for Formaldehyde<br />

33. National Institute of Occupational Safety<br />

and Health’s (NIOSH) Standards for<br />

Formaldehyde<br />

4<br />

LWFR-EXP5-000459<br />

PSC021693 –<br />

PSC021694<br />

PSC003158 –<br />

PSC003172<br />

PSC003173 –<br />

PSC003186<br />

PSC021695 –<br />

PSC021753<br />

PSC021754 –<br />

PSC021772<br />

To be supplemented<br />

PSC024278 –<br />

PSC024358<br />

34. NIOSH Pocket Guide LWFR-EXP3-000257<br />

35. Housing and Urban Development’s To be supplemented<br />

(HUD) Standards for Formaldehyde<br />

(including but <strong>no</strong>t limited to 24 C.F.R. §<br />

3280.308)<br />

36. World Health Organization (WHO) and<br />

Health Canada’s Standards for<br />

Formaldehyde<br />

37. American National Standard (ANSI) for<br />

Medium Density Fiberboard dated<br />

February 4, 1994<br />

PSC024359 –<br />

PSC024361<br />

PSC021773 –<br />

PSC021784<br />

38. American National Standard (ANSI) for PSC021785 –


Particleboard dated February 8, 1999<br />

39. ANSI A119.2, NFPA 1192: Standard on<br />

Recreational Vehicles; 2002 Edition<br />

40. ANSI A119.4, NFPA 1194: Standard on<br />

Recreational Vehicle Parks and<br />

Campgrounds; 2002 Edition<br />

41. ANSI/HPVA HP-1; American National<br />

Standard for Hardwood and Decorative<br />

Plywood<br />

42. Toxicological Profile on Formaldehyde<br />

prepared by ATSDR on July 1999<br />

43. Codes and Standards for Recreational<br />

Vehicles ANSI 119.2, NFPA 1192.<br />

44. Any and all standards adopted and/or in<br />

use from 2005 to present by the<br />

Recreational Vehicle Industry<br />

Association (RVIA)<br />

5<br />

PSC021797<br />

DUB002054 –<br />

DUB002100<br />

PSC021798 –<br />

PSC021817<br />

To be supplemented<br />

PSC024362 –<br />

PSC024829<br />

Including, but <strong>no</strong>t limited<br />

to LWFR-EXP5-000460-<br />

LWFR-EXP5-000461<br />

To be supplemented<br />

45. RVIA Standards LWFR-EXP5-000460-<br />

LWFR-EXP5-000461<br />

46. Building Code of the City of New To be supplemented<br />

Orleans, Louisiana<br />

47 2006 International Building Code LWFR-EXP5-000579-<br />

(excerpts)<br />

LWFR-EXP5-000583<br />

48. 2006 International Residential Code LWFR-EXP5-000584-<br />

LWFR-EXP5-000589<br />

49. ASCE 7 To be supplemented<br />

50. ASTM A-36 To be supplemented<br />

51. FEMA Model Travel Trailer To be supplemented<br />

Procurement Specifications<br />

52. Clean Air Act Extension of 1970 To be supplemented<br />

53. Clean Air Act Amendments of 1990 To be supplemented<br />

54. Dometic Brochure LWSR-EXP10-001334-<br />

LWSR-EXP10-001350<br />

55. New Source Performance Standards To be supplemented<br />

(NSPS)<br />

56. National Emissions Standards for To be supplemented<br />

Hazardous Air Pollutants (NESHAP)<br />

57. National Ambient Air Quality Standards To be supplemented<br />

(NAAQS)<br />

58. OSHA Formaldehyde Standards To be supplemented<br />

59. World Health Organization, 2000, Air To be supplemented<br />

Quality Guidelines for Europe; General<br />

Public


60. Suburban Manufacturing Corporation’s To be supplemented<br />

Manufacturer’s Instructions<br />

61. September 1, 2005, Memo from Doug To be supplemented<br />

Gaeddert to Mike Farrell at NACS<br />

62. National Electrical Code; Article 551 To be supplemented<br />

63. NISOH Pocket Guide to Chemical LWFR-EXP3-000257<br />

Hazards, 2005<br />

64. Excerpts from 2005 Hardwood Plywood To be supplemented<br />

Veneer Association “Where to Buy” pp.<br />

78-84<br />

65. Construction Manuals (Manual of Steel LWFR-EXP5-000457-<br />

Construction, Minimum Design Loads, LWFR-EXP5-000459<br />

Timber Construction Manual)<br />

66. <strong>US</strong>EPA, Indoor Air Quality-Basic To be supplemented<br />

Information-Formaldehyde, Washington<br />

DC, 2007<br />

http://epa.gov/iaq/formalde.html<br />

67. <strong>US</strong>DOL, OSHA, OSHA Formaldehyde To be supplemented<br />

Standards,Washington DC, 2008<br />

http://wvvw.osha.gov/SLTC/formaldehy<br />

de/standards.html<br />

68. World Health Organization, Air Quality To be supplemented<br />

Guidelines for Europe-Formaldehyde,<br />

Copenhagen, DE, 2001<br />

http://www.euro.who.int/document/aiq/5<br />

_8<strong>formaldehyde</strong>.pdf<br />

69. Health Canada, Residential Indoor Air To be supplemented<br />

Quality Guideline-Formaldehyde, 2006<br />

http://hc-sc.gc.calewh-selnt/alt<br />

forn1ats/hecssesc/pdf/pubs/air/<strong>formaldehyde</strong>-eng.pdf<br />

70. NIOSH, NIOSH Pocket Guide to<br />

Chemical Hazards, 2005<br />

http://www.cdc/gov/niosh/npg/npgd0293<br />

To be supplemented<br />

.html<br />

71. NIOSH, Method 2016 (Formaldehyde),<br />

Issue 2, NIOSH Manual of Analytical<br />

Methods (NMAM), Fourth Edition, 2003<br />

http://www.cdc.gov/Niosh/nmam/pdfs/2<br />

016.pdf<br />

72. ACGIH, Documentation of Threshold<br />

Limit Values and Biological Exposure<br />

Indices, 2001<br />

6<br />

LWFR-EXP 11-001662 –<br />

LWFR-EXP 11-001668<br />

LWFR-EXP11-000136 –<br />

LWFR-EXP11-000137<br />

73. Singh, Distribution of Selected Gaseous LWFR-EXP11-000138 -


Organic Mutagens and Suspect LWFR-EXP11-000146<br />

Carci<strong>no</strong>gens In Ambient Air<br />

74. ASHRAE – 62.2 Ventilation and<br />

Acceptable Indoor Air Quality in Low<br />

LWFR-EXP11-000147 –<br />

LWFR-EXP11-000222<br />

Rise Residential Buildings<br />

75. AHSRAE Standard 62.1 - 2004 LWFR-EXP11-000223 –<br />

LWFR-EXP11-000224<br />

76. ASTM – 1827 Blower Door LWFR-EXP11-000225 –<br />

LWFR-EXP11-000236<br />

77. ASTM E 1333 LWFR-EXP11-000237 –<br />

LWFR-EXP11-000248<br />

78. ATSDR 2007 Update Report LWRF-EXP11-000253 –<br />

LWFR-EXP11-000293<br />

79. ATSDR 2007 Report FEMA Temporary<br />

Housing Units<br />

LWFR-EXP 11-000772-<br />

LWFR-EXP 11-000785<br />

80. ATSDR Revised Report Baton Rouge LWFR-EXP 11-000786 –<br />

7<br />

LWFR-EXP 11-000826<br />

LWFR-EXP 11-000870 –<br />

LWFR-EXP 11-000883<br />

81. ATSDR Toxicological Profile for<br />

Formaldehyde<br />

82. CTEH Protocol LWFR-EXP 11-001032 –<br />

LWFR-EXP 11-001049<br />

83. Defendants’ Protocol LWFR-EXP 11-001050 –<br />

LWFR-EXP 11-001067<br />

84. Fact Sheet Early Findings LWFR-EXP 11-001193 –<br />

LWFR-EXP 11-001194<br />

85. FEMA Job Hazard Analysis Chart LWFR-EXP 11-001289<br />

86. HCOH in Houston Houses LWFR-EXP 11-001440 –<br />

LWFR-EXP 11-001444<br />

87. HCOH in LA CA Air - Grosjean LWFR-EXP 11-001445 –<br />

LWFR-EXP 11-001453<br />

88. HCOH in Mobil Homes LWFR-EXP 11-001454 –<br />

LWFR-EXP 11-001455<br />

89. HCOH in Urban Air LWFR-EXP 11-001456 –<br />

LWFR-EXP 11-001459<br />

90. Hodgson, VOCs in Indoor Air LWFR-EXP 11-001476 –<br />

LWFR-EXP 11-001506<br />

91. Litelpo, Inhaled HCOH LWFR-EXP 11-001507 –<br />

LWFR-EXP 11-001536<br />

92. LBNL-254E Final Report LWFR-EXP 11-001569 –<br />

LWFR-EXP 11-001629<br />

93. Lemus Study LWFR-EXP 11-001630 –<br />

LWFR-EXP 11-001639<br />

94. Long term Particleboard Emission<br />

Decay Study<br />

LWFR-EXP 11-001640 –<br />

LWFR-EXP 11-001643


95. Any and all Federal, State, Local, and<br />

Industry Regulations and Guidelines<br />

discussed and relied upon by any<br />

Defendant and/or Plaintiff experts in this<br />

matter.<br />

Articles<br />

96. July 20, 2007 “Formaldehyde and<br />

FEMA Trailers” by Lee Shull, Ph.D<br />

97. Maddalena, Randy; Russell, Marion;<br />

Sullivan, Douglas P.; an Apte, Michael<br />

G. “Aldehyde and Other volatile Organic<br />

Chemical Emissions in Four FEMA<br />

Temporary Housing Unites-Final<br />

Report”-Ernest Orlando Lawrence<br />

Berkeley National Laboratory,<br />

November 2008<br />

98. “Effect of Formaldehyde Inhalation on<br />

Hsp70 in Seminiferous Tubules of rat<br />

testes: an immu<strong>no</strong>histochemical study”<br />

by O. Ozen, et al. (2005)<br />

99. “Formaldehyde and Glutaradehyde and<br />

nasal Cytotoxicity: Case Study within<br />

the Context of the 2006 IPCS Human<br />

Framework for the Analysis of a Cancer<br />

Mode of Action for Humans” by D.<br />

McGregor, et al.<br />

100. “Effects of Inhaled Formaldehyde on<br />

Learning and Memory of Mice” by Z.<br />

Lu, et al. (2008)<br />

101. “Low Concentrations of Formaldehyde<br />

induce DNA damage and delay DNA<br />

repair after UV irradiation in Human<br />

Skin Cells” by G. Emri, et al. (2004)<br />

102. National Cancer Institute (NCI): Fact<br />

Sheet: Formaldehyde and Cancer Risk<br />

dated May 7, 2009<br />

103. National Cancer Institute (NCI):<br />

Formaldehyde Exposure among<br />

Industrial Workers is Associated with<br />

Increased Risk of Cancers of the Blood<br />

and Lymphatic System dated May 12,<br />

2009<br />

104. FEMA media release: FEMA Awards<br />

Contracts for Low Emissions Travel<br />

To be supplemented<br />

PSC021640 –<br />

PSC021641<br />

PSC025133 –<br />

PSC025193<br />

PSC021823 –<br />

PSC021829<br />

PSC021830 –<br />

PSC021846<br />

PSC021847 –<br />

PSC021854<br />

PSC021855 –<br />

PSC021866<br />

PSC021867 –<br />

PSC02<strong>1873</strong><br />

PSC026117 –<br />

PSC026118<br />

PSC021876 –<br />

PSC021879<br />

8


Trailers – April 7, 2009 – Release No.<br />

HQ-09-034b<br />

105. FEMA media release: FEMA to<br />

Introduce New Type of Manufactured<br />

Home – Dec. 18, 2008 – Release No.<br />

1791-343<br />

106. Article – “Formaldehyde Exposure in<br />

No<strong>no</strong>ccupational Environments” by K.<br />

Dally, et al.<br />

107. Article – “Formaldehyde-related Health<br />

Complaints of Residents Living in<br />

Mobile and Conventional Homes” by I.<br />

Ritchie, et al.<br />

108. Article – FEMA rolls out new disaster<br />

mobile homes: Formaldehyde levels are<br />

far below those of Hurricane Katrina,<br />

Rita <strong>trailer</strong>s dated 05/14/09<br />

109. Fact Sheet: Airborne Toxic Control<br />

Measure (ATCM) to Reduce<br />

Formaldehyde Emissions from<br />

Composite Wood Products<br />

110. Environmental Health – Formaldehyde<br />

Exposure in Homes: A Reference for<br />

State Officials to Use in Decision-<br />

Making (March 2008)<br />

111. Environmental Health – What you<br />

should k<strong>no</strong>w about Formaldehyde in<br />

Mobile Homes<br />

112. Formaldehyde Levels in FEMA-<br />

Supplied Trailers; Early Findings from<br />

the Centers for Disease Control and<br />

Prevention<br />

113. “Formaldehyde Indoors” by Dr. Stephen<br />

Smulski, April 1987, Progressive<br />

Builder, 12(4):9-11.<br />

114. Boyson, M. “Nasal mucosa in workers<br />

exposed to <strong>formaldehyde</strong>: a pilot study.”<br />

Br J of Ind Med 47:116-121, 1990<br />

115. Edling, C. “Occupational exposure to<br />

<strong>formaldehyde</strong> and histopathological<br />

changes in nasal mucosa.” Br J of Ind<br />

Med 45:761-765, 1988<br />

116. Holmstrom, M. “Histological Changes<br />

in the Nasal Mucosa in Rats after Long-<br />

PSC021880<br />

PSC021881 –<br />

PSC021888<br />

PSC021889 –<br />

PSC021894<br />

PSC021895 –<br />

PSC021896<br />

PSC026119 –<br />

PSC026120<br />

PSC021897 –<br />

PSC021902<br />

PSC021903 –<br />

PSC021906<br />

PSC003218 –<br />

PSC003219<br />

PSC002752 –<br />

PSC002754<br />

PSC002845 –<br />

PSC002853<br />

PSC002854 –<br />

PSC002865<br />

PSC002866 –<br />

PSC002881<br />

9


term Exposure to Formaldehyde and<br />

Wood Dust.” Acta Otolaryngol (Stockh)<br />

108:274-283, 1989<br />

117. Holmstrom, M. “Histological Changes<br />

in the Nasal Mucosa in Persons<br />

Occupationally Exposed to<br />

Formaldehyde Alone and in<br />

Combination with Wood Dust.” Acta<br />

Otolaryngol (Stockh) 107:120-129, 1989<br />

118. Garrett, MH. “Increased risk of allergy<br />

in children due to <strong>formaldehyde</strong><br />

exposure in homes.” Allergy 1999;<br />

54(4):330-7.<br />

119. Jaakkola, JJ. “Asthma, Wheezing, and<br />

Allergies in Russian Schoolchildren in<br />

Relation to New Surface Materials in the<br />

Home.” Am J Public Health<br />

2004;94(4):560-2<br />

120. Platts-Mills, TA. “Indoor allergens and<br />

asthma: Report of the Third<br />

International Workshop.” J Allergy Clin<br />

Immu<strong>no</strong>l 1997;100(6 Pt 1):S2-S24.<br />

121. “Legacy of Shame: The On-Going<br />

Public Health Disaster of Children<br />

Struggling in Post-Katrina Louisiana.”<br />

Children’s Health Fund & Columbia<br />

Univ. Mailman School of Public Health,<br />

Nov. 4, 2008<br />

122. “Children from FEMA <strong>trailer</strong> park battle<br />

serious health problems” <strong>US</strong>A Today<br />

11/24/08<br />

123. Wantke, F, “Exposure to gaseous<br />

<strong>formaldehyde</strong> induces IgE-mediated<br />

sensitization to <strong>formaldehyde</strong> in schoolchildren”<br />

Clinical and Experimental<br />

Allergy, 1996, Vol. 26, pages 276-280<br />

124. Krzyza<strong>no</strong>wski, Michal, “Chronic<br />

Respiratory Effects of Indoor<br />

Formaldehyde Exposure” Environmental<br />

Research 52, 117-125 (1990)<br />

125. “Indoor Residential Chemical Emissions<br />

as Risk Factor for Children’s<br />

Respiratory Health” by M. Mendell<br />

10<br />

PSC002882 –<br />

PSC002893<br />

PSC002898 –<br />

PSC002905<br />

PSC002906 –<br />

PSC002909<br />

PSC002909 –<br />

PSC002931<br />

PSC006033 –<br />

PSC006052<br />

PSC006053 –<br />

PSC006054<br />

PSC006055 –<br />

PSC006059<br />

PSC006060 –<br />

PSC006068<br />

PSC022228 –<br />

PSC022267<br />

126. “Formaldehyde and Leukemia: PSC026121 –


Epidemiology, Potential Mechanisms,<br />

and Implications for Risk Assessment”<br />

by Zhang, et al.<br />

127. “Formaldehyde-releasers: relationship to<br />

<strong>formaldehyde</strong> contact allergy. Contact<br />

allergy to <strong>formaldehyde</strong> and inventory of<br />

<strong>formaldehyde</strong>-releasers” by Groot, et al.<br />

128. “Prospective study of clinical symptoms<br />

and skin test reactions in medical<br />

students exposed to <strong>formaldehyde</strong> gas”<br />

by Takahashi, et al.<br />

129. “Influence of airborne nitrogen dioxide<br />

or <strong>formaldehyde</strong> on parameters of skin<br />

function and cellular activation in<br />

patients with atopic eczema and control<br />

subjects” by Eberlein-Konig, et al.<br />

130. Zinn, T.,D., Cline and W. Lehmann,<br />

Long Term Study of Formaldehyde<br />

Emission Decay from Particleboard,<br />

Forest Products Journal, June 1990.<br />

131. 2007 An Update and Revision of<br />

ATSDR’S February 2007 Health<br />

Consultation: Formaldehyde Sampling<br />

of FEMA Temporary-Housing Trailers<br />

Baton Rouge, Louisiana, September-<br />

October, 2006. U.S. Department of<br />

Health and Human Services Public<br />

Health Agency for Toxic Substances and<br />

Disease Registry. Atlanta Georgia.<br />

132. 2004. ANSI/HPVA Hp-1-2004<br />

American National Standard for<br />

Hardwood and Decorative Plywood.<br />

HPVA. Reston, Virginia.<br />

133. 1986. From Start to Finish<br />

Particleboard. National Particleboard<br />

Association. Gaithersburg, Maryland.<br />

134. 1986. From Start to Finish Medium<br />

Density Fiberboard. National<br />

Particleboard<br />

Association.<br />

Gaithersburg, Maryland.<br />

135. 2003. VOC Emission Barrier Effect of<br />

Laminates, Overlays and Coatings for<br />

Particleboard, Medium Density<br />

Fiberboard (MDF) and hardboard.<br />

PSC026131<br />

PSC026132 –<br />

PSC026154<br />

JAMES-008350<br />

JAMES-008356<br />

JAMES-008357<br />

JAMES-008359<br />

To be supplemented<br />

LWFR-EXP11-000253-<br />

LWFR-EXP11-000293<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

11


Composite Panel Association.<br />

Gaithersburg, Maryland.<br />

136. Barry, A. and D. Corneau. 2006.<br />

Effectiveness of barriers to minimize<br />

VOC emissions including <strong>formaldehyde</strong>.<br />

Forest Products Journal. 56(9):38-42<br />

137. Groah, W., G. Gramp and M. Trant.<br />

1984. Effect of a decorative vinyl<br />

overlay on <strong>formaldehyde</strong> emissions.<br />

Forest Products Journal 34(4):27-29.<br />

138. J. Thompson, et al., “Malingering” in<br />

Textbook of Forensic Psychiatry (2004),<br />

p. 427-449<br />

139. Seattle Times Op-Ed, June 6, 1980, A-7,<br />

“Formaldehyde Not Dangerous”<br />

140. Paustenbach, Dennis, Corporate<br />

Occupational Exposure Limits the<br />

Current State of Affairs, AIHA Journal,<br />

1986<br />

141. Atchison, J. and Brown, J., The<br />

Log<strong>no</strong>rmal Distribution, Cambridge<br />

University Press, 1957<br />

142. William H. Bullock, et al., A Strategy for<br />

Assessing and managing Occupational<br />

Exposures, AIHA (2006) (excerpts)<br />

143. Esman, et al, Log-Normality of<br />

Environmental Sampling Data, Journal<br />

of Environmental Science and Health<br />

(1977)<br />

144. Falk, Eric K., A Short Explanation of<br />

Retrospective Exposure Assessment and<br />

its Use in Toxic Tort Litigation, Toxic<br />

Torts and Environmental Law<br />

Committee Newsletter (Winter 2009)<br />

145. Gibbons and Coleman, Statistical<br />

Methods for Detection and<br />

Quantification of Environmental<br />

Contamination (2001)<br />

146. Glibert, Richard O., Statistical Methods<br />

for Environmental Pollution Monitoring<br />

(excerpts) (1987)<br />

147. Hewett, Paul, Mean Testing: II.<br />

Comparison of Several Alternative<br />

Procedures, Applied Occupational and<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

LWFR-GEN-000081<br />

LWFR-EXP3-000071-<br />

LWFR-EXP3-000080<br />

LWFR-EXP3-000081-<br />

LWFR-EXP3-000086<br />

LWFR-EXP3-000087-<br />

LWFR-EXP3-000099<br />

LWFR-EXP3-000100-<br />

LWFR-EXP3-000112<br />

LWFR-EXP3-000113-<br />

LWFR-EXP3-000114<br />

LWFR-EXP3-000115-<br />

LWFR-EXP3-000122<br />

LWFR-EXP3-000123-<br />

LWFR-EXP3-000129<br />

LWFR-EXP3-000130-<br />

LWFR-EXP3-000138<br />

12


Environmental Hygiene (1997)<br />

148. Hewett, Paul, “Chapter 16. Industrial<br />

Hygiene Exposure Assessment – Data<br />

Analysis and Interpretation”, from<br />

Handbook of Chemical Safety and<br />

Health (2001)<br />

149. Hodgson, et al., Volatile Organic<br />

compound Concentrations and Emission<br />

Rates in New Manufactured and Site-<br />

Built Homes, Indoor Air (2000)<br />

150. Land, C.E., Tables of Confidence Limits<br />

for Linear Functions of the Normal<br />

Mean and Variance, American<br />

Mathematical Society (1975)<br />

151. Nielsen, et al., Chemical and Biological<br />

Evaluation of Building Material<br />

Emissions, Indoor Air (1997)<br />

152. Paustenbach, Dennie, Occupational<br />

Exposure Limits, Pharmacokinetics, and<br />

Unusual Work Schedules (Chapter 7)<br />

(1994)<br />

153. Suta, Benjamin, Population Exposures<br />

to Atmospheric Formaldehyde Inside<br />

Residences, report to EPA (1980)<br />

154. Versar Final Report: “Formaldehyde<br />

Exposure Model – Description and<br />

Demonstration” (1986)<br />

155. Viet, et al., Guideline on Occupational<br />

Exposure Reconstruction, AIHA<br />

Guideline 11-2008<br />

156. White, et al., Principles of Exposure<br />

Measurement in Epidemiology,<br />

(excerpts) Oxford University Press<br />

(2008)<br />

157. Helena Ribeiro, Sugar Cane Burning in<br />

Brazil: Respiratory Health Effects, Rev.<br />

Saude Publica Vol. 42 <strong>no</strong>.2 Sao Paulo<br />

Apr. 2008 Epub February 29, 2008<br />

158. Lewis, Sax’s Dangerous Properties of<br />

Industrial Materials Tenth Edition and<br />

Hawley’s Condensed Chemical<br />

Dictionary Thirteenth Edition, Wiley,<br />

Hoboken, NJ, 2000.<br />

13<br />

LWFR-EXP3-000139-<br />

LWFR-EXP3-000169<br />

LWFR-EXP3-000217-<br />

LWFR-EXP3-000232<br />

LWFR-EXP3-000233-<br />

LWFR-EXP3-000239<br />

LWFR-EXP3-000241-<br />

LWFR-EXP3-000256<br />

LWFR-EXP3-000258-<br />

LWFR-EXP3-000259<br />

LWFR-EXP3-000260-<br />

LWFR-EXP3-000272<br />

LWFR-EXP3-000279-<br />

LWFR-EXP3000272<br />

LWFR-EXP3-000280-<br />

LWFR-EXP3-000285<br />

LWFR-EXP3-000286-<br />

LWFR-EXP3-000290<br />

LWFR-EXP7-009919-<br />

LWFR-EXP7-009926<br />

To be supplemented<br />

159. California EPA, ARB, Indoor Air To be supplemented


Quality Guideline-Formaldehyde in the<br />

Home, 2004<br />

http://www.arb.ca.gov/researchiindoor/f<br />

ormaldg108-04.pdf<br />

160. Formaldehyde Sampling: Active and<br />

Passive Sampling Protocols, DeVany,<br />

2008<br />

161. AIHA, AIHA Field Guide for<br />

Determination of Biological<br />

Contaminants , Second Edition, 2005<br />

162. Casset A, Purohit A, Marchand C, et al.:<br />

“The Bronchial response to inhaled<br />

<strong>formaldehyde</strong>”<br />

163. Dingle P; “Formaldehyde in Occupied<br />

and U<strong>no</strong>ccupied Caravans in Australia”<br />

164. Songul Acar Vaizoglu; “Determining<br />

Domestic Formaldehyde Levels in<br />

Ankara, Turkey”<br />

165. Fenna A Ebbens, MD, MSc; “The Mold<br />

Conundrum in Chronic Rhi<strong>no</strong>sinusitis:<br />

Where Do We Stand Today?”<br />

166. American College of Occupational and<br />

Environmental Medicine “Adverse<br />

Human Health Effects Associated with<br />

Molds in the Indoor Environment”<br />

167. Affidavit of Patricia M. Williams, PH.D.<br />

D.A..B.T. in the Trial of Alana<br />

Alexander And Christopher Cooper<br />

168. Allenby CF, Basketter DA; “The effect<br />

of repeated open exposure to low levels<br />

of nickel on compromised hand skin of<br />

nickel-allergic subjects”<br />

14<br />

To be supplemented<br />

To be supplemented<br />

LWFR-EXP15-000131-<br />

LWFR-EXP15-000141<br />

LWFR-EXP15-000142-<br />

LWFR-EXP15-000147<br />

LWFR-EXP15-000148-<br />

LWFR-EXP15-000155<br />

LWFR-EXP15-000156-<br />

LWFR-EXP15-000164<br />

LWFR-EXP15-000209-<br />

LWFR-EXP15-000222<br />

LWFR-EXP15-000223-<br />

LWFR-EXP15-000264<br />

LWFR-EXP15-000165-<br />

LWFR-EXP15-000169<br />

169. Allergen Patch Test-Information of<br />

Patients<br />

LWFR-EXP15-000265-<br />

LWFR-EXP15-000303<br />

170. Allergen Patch Test-TRUE test LWFR-EXP15-000304-<br />

LWFR-EXP15-000345<br />

171. D. Sciandra, F. Dispenza, R. Porcasi. G.<br />

Kulamarva, C. Saraniti,<br />

Otorhi<strong>no</strong>laryngology Department;<br />

Human Pathology Department,<br />

University of Palermo, Italy; ENT<br />

Clinic, Nayak’s Road, Kasaragod, India<br />

“Pleomorphic ade<strong>no</strong>ma of the lateral<br />

nasal wall: case report”<br />

LWFR-EXP15-000170-<br />

LWFR-EXP15-000173


172. Josje H. E. Arts, Carolien Mommers,<br />

and Cees de Heer “Dose-Response<br />

Relationships and Threshold Levels in<br />

Skin and Respiratory Allergy”<br />

173. Ralph J Delfi<strong>no</strong>, Henry Gong, Jr.,<br />

William S. Linn, Edo D. Pellizzari, and<br />

Ye Hu “Asthma Symptoms in Hispanic<br />

Children and Daily Ambient Exposures<br />

to Toxic and Criteria Air Pollutants”<br />

15<br />

LWFR-EXP15-000174-<br />

LWFR-EXP15-000208<br />

LWFR-EXP15-000346-<br />

LWFR-EXP15-000356<br />

174. Author Reply; Comment LWFR-EXP15-000357-<br />

LWFR-EXP15-000359<br />

175. M.A. Anderson, M. Nikulin, U. Koljalg,<br />

M. Anderson, F. Rainey, K. Reijula, E. –<br />

L Hintikka, and M. Salki<strong>no</strong>ja-Salonen<br />

“Bacteria, Molds, and Toxins in Water-<br />

Damaged Building Materials”<br />

LWFR-EXP15-000360-<br />

LWFR-EXP15-000366<br />

176. Bender, J; “The use of <strong>no</strong>ncancer<br />

endpoints as a basis for establishing a<br />

reference concentration for<br />

<strong>formaldehyde</strong>”<br />

178. Hodgson, Michael J. Md, MPH; Morey,<br />

Philip, PhD; Leung, Wing-Yan, BS;<br />

Morrow, Lisa PhD; Miller, David, PhD;<br />

Jarvis, Bruce, PhD; Robbins, Howard,<br />

MD;<br />

Halsey, John F. PhD; Storey, Eileen,<br />

MD, MPH; “Building-Associated<br />

Pulmonary Disease from Exposure to<br />

Stachbotrys chartarum and Apsergillus<br />

versicolor”<br />

179. Stuart M. Brooks, Wil Spaul and James<br />

D. McCluskey “The Spectrum of<br />

Building-Related Airway Disorders”<br />

180. J.H Olsen, L. Dragstead & H. Autrup<br />

“Cancer Risk and occupational exposure<br />

to aflatoxins in Denmark”<br />

181. CDC Update “Pulmonary<br />

Hemorrhage/Hemosiderosis among<br />

Infants—Cleveland, Ohio, 1993-1996”<br />

January 17, 1997/46 (02); 33-35<br />

LWFR-EXP15-000367-<br />

LWFR-EXP15-000376<br />

177. Bissett, Drobatz, McKnight, Degernes;<br />

“Prevalence, clinical features, and causes<br />

of epistaxes in dogs”; 176 cases (1996-<br />

2001)<br />

LWFR-EXP15-000377-<br />

LWFR-EXP15-000385<br />

LWFR-EXP15-000386-<br />

LWFR-EXP15-000395<br />

LWFR-EXP15-000396-<br />

LWFR-EXP15-000405<br />

LWFR-EXP15-000406-<br />

LWFR-EXP15-000409<br />

LWFR-EXP15-000410-<br />

LWFR-EXP15-000412


182. CDC Update “Pulmonary<br />

Hemorrhage/Hemosiderosis among<br />

Infants—Cleveland, Ohio, 1993-1996”<br />

March 10, 2000-49 (09); 180-4<br />

183. Chalyasate, Roongrotwattansairi,<br />

Fooanan, Sumitsawan; “Epistaxis in<br />

Chiang Mai University Hospital”<br />

184. Chang “Contact Dermatitis<br />

1997:37:309”<br />

LWFR-EXP15-000413-<br />

LWFR-EXP15-000421<br />

LWFR-EXP15-000422-<br />

LWFR-EXP15-000427<br />

LWFR-EXP15-000428-<br />

LWFR-EXP15-000431<br />

185. Clement PA, Stoot AP, Kaufman L; the<br />

“Influence of <strong>formaldehyde</strong> on the nasal<br />

mucosa”<br />

186. Clinical and Pathogenic Microbiology<br />

(Second Edition)<br />

187. Pierre Auger, MD, Pierre Gourdeau,<br />

MD, and J. David Miller, PhD “Clinical<br />

Experience with Patients Suffering from<br />

a Chronic Fatigue-Like Syndrome and<br />

Repeated Upper Respiratory Infections<br />

in Relation to Airborne Molds”<br />

188. Torkel Fischer, Klaus Anderson, Ulla<br />

Bengtsson, Peter Frosch, Yen<br />

Gunnarssan, Bo Kreilgard, Torkil<br />

Menne, Stephanie Shaw, Louise<br />

Svennson, John Wilkinson “Clinical<br />

Standardization of the TRUE Test<br />

Formaldehyde Patch”<br />

189. Clinical Toxicology-Stachybotrys<br />

Revisited<br />

190. Douglas H. Linz, MD, MS; Susan M.<br />

Pinney, PhD; James D. Keller, MD, MS;<br />

Michael White, MS; C. Ralph Buncher,<br />

ScD; “Cluster Analysis Applied to<br />

Building-Related Illness”<br />

191. Code of Federal Regulations-29-Part<br />

1910-July 1990<br />

192. Luis M. de la Maza, M.D., Ph.D., Marie<br />

T. Pezzlo, M.A (AAM); Ellen Jo Baron.,<br />

F (AAM) “Color Atlas of Diag<strong>no</strong>stic<br />

Microbiology”<br />

193. Comment, Comment ILL Number:<br />

55546440<br />

16<br />

LWFR-EXP15-000432-<br />

LWFR-EXP15-000438<br />

LWFR-EXP15-000439-<br />

LWFR-EXP15-000440<br />

LWFR-EXP15-000441-<br />

LWFR-EXP15-000442<br />

LWFR-EXP15-000443-<br />

LWFR-EXP15-000449<br />

LWFR-EXP15-000450-<br />

LWFR-EXP15-000452<br />

LWFR-EXP15-000453-<br />

LWFR-EXP15-000459<br />

LWFR-EXP15-000460-<br />

LWFR-EXP15-000461<br />

LWFR-EXP15-000462-<br />

LWFR-EXP15-000463<br />

LWFR-EXP15-000464-<br />

LWFR-EXP15-000466<br />

194. P. Sherwood Burge, A.S Robertson, and LWFR-EXP15-000467-


A.Hedge “Comparison of Self-<br />

Administered Questionnaire with<br />

Physician Diag<strong>no</strong>sis in the Diag<strong>no</strong>sis of<br />

the Sick Building Syndrome”<br />

195. J.M Fernandez Vozmedia<strong>no</strong> and J.C<br />

Armario Hita “Concordance and<br />

discordance between TRUE Test and<br />

Finn Chamber”<br />

196. S. Iris Ale and Howard I. Maibach<br />

“Reproducibility of patch test results: a<br />

concurrent right-versus-left study using<br />

TRUE Test”<br />

197. Daele, Vander, Poorten, Rombaux,<br />

Hamoir; “Cancer of the nasal vestibule,<br />

nasal cavity and paranasal sinuses”<br />

198. Robert Dales MD MSc(Epid), Ling Liu<br />

MMD PhD, Amanda J. Wheeler PhD,<br />

Nicolas L. Gilbert MSc “Quality of<br />

indoor residential air and health”<br />

199. B. Brunekreef “Damp housing and adult<br />

respiratory symptoms”<br />

200. Chih-Shan Li, Ching-Wan HSU, Chia-<br />

Hui Lu “Dampness and Respiratory<br />

Symptoms among workers in Daycare<br />

Centers in a Subtropical Climate”<br />

201. T.L Brasel, D.R Douglas, S.C Wilson,<br />

and D.C Straus “Detection of Airborne<br />

Stachybotrys chartarum Macrocyclic<br />

Trichothecene Mycotoxins on<br />

Particulates Smaller than Conidia”<br />

202. Louise Arup Fischer, Torkil Menne, and<br />

Jeanne Duus Johansen “Dose per unit<br />

area-a study of elicitation of nickel<br />

allergy”<br />

203. Druce HM; “Nasal provocation<br />

challenge-strategies for experimental<br />

design”<br />

204. Paul Ar<strong>no</strong>w, M.D; Jordan Fink, M.D.;<br />

Donald Schleuter, M.D.; Joseph<br />

Barboriak, Sc.D.;<br />

George Mallison, M.P.H; Sami Said,<br />

M.D; Stanley Martin, M.S.; George<br />

Unger, M.D; Gerald Scanlon, M.D;<br />

Viswanath Kurup, Ph.D.; “Early<br />

LWFR-EXP15-000470<br />

LWFR-EXP15-000471-<br />

LWFR-EXP15-000472<br />

LWFR-EXP15-000473-<br />

LWFR-EXP15-000482<br />

LWFR-EXP15-000483-<br />

LWFR-EXP15-000493<br />

LWFR-EXP15-000494-<br />

LWFR-EXP15-000499<br />

LWFR-EXP15-000500-<br />

LWFR-EXP15-000504<br />

LWFR-EXP15-000505-<br />

LWFR-EXP15-000508<br />

LWFR-EXP15-000509-<br />

LWFR-EXP15-000517<br />

LWFR-EXP15-000523-<br />

LWFR-EXP15-000529<br />

LWFR-EXP15-000530-<br />

LWFR-EXP15-000536<br />

LWFR-EXP15-000537-<br />

LWFR-EXP15-000543<br />

17


Detection of Hypersensitivity<br />

Pneumonitis in Office Workers”<br />

205. Fenna A Ebbens, Christos Georgalas and<br />

Wytske J. Fokkens “Fungus as the cause<br />

of chronic rhi<strong>no</strong>sinusitis: the case<br />

remains unproven”<br />

206. Fenna A Ebbens, MD, MSc, and Wytske<br />

J. Fokkens, MD, PhD “The Mold<br />

Conundrum in Chronic Rho<strong>no</strong>sinusitis:<br />

Where Do We Stand Today?”<br />

207. Mario Nikulin, Kari Reijula, Bruce<br />

Jarvis, Pirio Veijalanien and Eeva-Liisa<br />

Hintikka<br />

“Effects of Intranasal Exp to Spores of<br />

Stachybotrys Atria in Mice”<br />

208. Noreen N. Khan and Bobby Wilson<br />

“Environmental Assessment of Mold<br />

Concentrations and Potential Mycotoxin<br />

in the Greater Southeast Texas Area”<br />

209. U.S Environmental Protection Agency<br />

“EPA Fine Particle PM 2.5<br />

Designations”<br />

18<br />

LWFR-EXP15-000544-<br />

LWFR-EXP15-000550<br />

LWFR-EXP15-000551-<br />

LWFR-EXP15-000559<br />

LWFR-EXP15-000560-<br />

LWFR-EXP15-000566<br />

LWFR-EXP15-000567-<br />

LWFR-EXP15-000581<br />

LWFR-EXP15-000582-<br />

LWFR-EXP15-000604<br />

210. EPA Safe Contaminent Chart LWFR-EXP15-000605-<br />

LWFR-EXP15-000610<br />

211. M. Lei<strong>no</strong>, M. Makela, K. Reijula, T.<br />

Haahtlat, H. Mussalo-Rauhamaa, T.<br />

Toumi, E-L Hintikka, and H. Alenius<br />

“Intranasal exposure to a damp building<br />

mould, Stachybotrys chartarum, induces<br />

lung inflammation in mice by satraxinindependent<br />

mechanisms”<br />

LWFR-EXP15-000611-<br />

LWFR-EXP15-000618<br />

212. Claus Zachariae, Barbara Hall, Martine<br />

Cottin, Sylve Cupferman, Klaus<br />

Andersen, T. Menne “Experimental<br />

elicitation of contact allergy from a<br />

diazolidinyl uera-preserved cream in<br />

relation to anatomical region, exposure<br />

time and concentration”<br />

213. Marjo Nikulin, Kari Reijula, Bruce B<br />

Jarvis, and Eeva-Liisa Hintikka<br />

“Experimental Lung Mycotoxicosis in<br />

Mice Induced by Stachybotrys Atra”<br />

214. L.A. Fischer, J.D Johnson, and T. Menne<br />

“Methyldibromoglutaronitrile allergy:<br />

LWFR-EXP15-000619-<br />

LWFR-EXP15-000629<br />

LWFR-EXP15-000630-<br />

LWFR-EXP15-000634<br />

LWFR-EXP15-000635-<br />

LWFR-EXP15-000641


elationship between patch test and<br />

repeated open application test<br />

thresholds”<br />

215. Lawrence Fishbein, PhD “Exposure<br />

from occupational versus other sources”<br />

216. Floods Carry Potential for Toxic Mold<br />

Disease; May 1997<br />

217. Flyvholm MA, Hall BM, et al;<br />

Threshold for occluded <strong>formaldehyde</strong><br />

patch test in <strong>formaldehyde</strong>-sensitive<br />

patients. Relationship to repeated open<br />

applica”<br />

218. Peter Franklin, Peter Dingle, and<br />

Stephen Stick “Raised Exhaled Nitric<br />

Oxide in Healthy Children is Associated<br />

with Domestic Formaldehyde Levels”<br />

219. Karl E. Frees, et al “Severe complication<br />

after administration if formalin for<br />

treatment of progressive ethomidal<br />

hematoma in a horse”.<br />

220. Kazuyasu Fujii, et al “Effect of<br />

<strong>formaldehyde</strong> Gas Exposure in a Marine<br />

Allergic Contact Hypersensitivity<br />

Model”<br />

221. Fran Fisher., M.T. (ASCP), et al<br />

“Fundamentals of Diag<strong>no</strong>stic<br />

Mycology”<br />

19<br />

LWFR-EXP15-000642-<br />

LWFR-EXP15-000654<br />

LWFR-EXP15-000655-<br />

LWFR-EXP15-000656<br />

LWFR-EXP15-000657-<br />

LWFR-EXP15-000665<br />

LWFR-EXP15-000666-<br />

LWFR-EXP15-000668<br />

LWFR-EXP15-000669-<br />

LWFR-EXP15-000670<br />

LWFR-EXP15-000671-<br />

LWFR-EXP15-000684<br />

LWFR-EXP15-000685-<br />

LWFR-EXP15-000686<br />

222. James Gibson “Formaldehyde Toxicity” LWFR-EXP15-002177-<br />

LWFR-EXP15-002178<br />

223. Gollhausen Rainer, et al<br />

“Reproducibility of patch test results;<br />

Comparison of TRUE Test and Finn<br />

Chamber Test Results”<br />

LWFR-EXP15-000687-<br />

LWFR-EXP15-000691<br />

224. Gottschalk C, Bauer J, Meyer K.;<br />

“Detection of Satratoxin G and H Indoor<br />

Air from a Water-Damaged Building”<br />

225. Gutarowska B, Wiszniewska M, et al;<br />

“Exposure to moulds in flats and the<br />

prevalence of allergic diseasespreliminary<br />

study”<br />

LWFR-EXP15-000692-<br />

LWFR-EXP15-000697<br />

LWFR-EXP15-000698-<br />

LWFR-EXP15-000706<br />

226. Unk<strong>no</strong>wn, Erratum LWFR-EXP15-000707-<br />

LWFR-EXP15-000708<br />

227. R.W Hanckel, M.D., and Richard Carter,<br />

M.D.; “Epistaxis”<br />

LWFR-EXP15-000709-<br />

LWFR-EXP15-000714


228. Haraguchi, Ebihara, Saikawa, et al;<br />

“Malignant tumors of the nasal cavity;<br />

review of a 60-case series”<br />

229. Hata, H, Taka<strong>no</strong> H, Matsumiya G., et al;<br />

“Late complications of gelatin-resorcinformalin<br />

glue in the repair of acute type<br />

A aortic dissection”<br />

230. Jun-ichi Hattori, MD, et al;<br />

“Bronchospasm Induced by Propofol in<br />

a Patient with Sick House Syndrome”<br />

20<br />

LWFR-EXP15-000715-<br />

LWFR-EXP15-000723<br />

LWFR-EXP15-000724-<br />

LWFR-EXP15-000731<br />

LWFR-EXP15-000732-<br />

LWFR-EXP15-000733<br />

231. Hazard Communication LWFR-EXP15-000734-<br />

LWFR-EXP15-000756<br />

232. Eckardt Johanning, et al; “Health and<br />

Immu<strong>no</strong>logy study following exposure<br />

to toxigenic fungi (Stachybotrys<br />

chartarum) in a water damaged office<br />

environment”<br />

LWFR-EXP15-000757-<br />

LWFR-EXP15-000768<br />

233. Peter Kozak Jr.; “Home Mold Surveys” LWFR-EXP15-000769-<br />

LWFR-EXP15-000778<br />

234. IARC Vol 100 F- A review of human LWFR-EXP 15-000779<br />

carci<strong>no</strong>gens Part F<br />

235. Imidazolidinyl Urea 39236-46-9 LWFR-EXP15-000780-<br />

LWFR-EXP15-000797<br />

236. Immu<strong>no</strong>logy 7th Edition -<br />

Hypersensitivity Type IV - Chapter 26<br />

LWFR-EXP15-000798-<br />

LWFR-EXP15-000800<br />

237. Dales, Robert, et al; “ndoor Air Quality<br />

and Health; Reproducibility of<br />

Respiratory Symptoms and Reported<br />

Home Dampness and Molds using a<br />

Self-Administered Questionnaire”<br />

LWFR-EXP15-000801-<br />

LWFR-EXP15-000806<br />

238. D.M Kuhn and M.A Ghan<strong>no</strong>um “Indoor<br />

Mold, Toxigenic Fungi, and<br />

Stachybotrys Charatarum: Infectious<br />

Disease Perspective”<br />

239. Ana Rask-Anderson, et al; “Inhalation<br />

Fever and Respiratory Symptoms in<br />

Swedish Sawmills”<br />

240. Izulani H. Shibukawa, et al; Devasting<br />

late complication for repair of type A<br />

Acute aortic dissection with usage of<br />

gelatin-resorci<strong>no</strong>l-formalin glue”<br />

241. C. Janson, et al; “European Community<br />

Respiratory Health Survey: What are the<br />

main results so far?”<br />

LWFR-EXP15-000807-<br />

LWFR-EXP15-000835<br />

LWFR-EXP15-000836-<br />

LWFR-EXP15-000838<br />

LWFR-EXP15-000839-<br />

LWFR-EXP15-000844<br />

LWFR-EXP15-000845-<br />

LWFR-EXP15-000858


242. Jerzy Kaminski, et al; “Determination of<br />

Formaldehyde in Fresh and Retail Milk<br />

by Liquid Colmn Chromatography”<br />

243. Teruhisa Kazui, MD, et al; “Role of<br />

Biologic Glue Repair of Proximal Aortic<br />

Dissection in the Development of Early<br />

and Midterm Redissection of the Aortic<br />

Root”<br />

244. Edward Kerfoot, PhD., et al;<br />

“Formaldehyde and Para<strong>formaldehyde</strong><br />

Study in Funeral Homes”<br />

245. Matthias Kirsch, MD., et al; “Aortic<br />

Alterations After Use of Gelatin-<br />

Resorci<strong>no</strong>l-Formalin Glue”<br />

246 Jame Koenig, PhD.; “Indoor and outdoor<br />

pollutants and the upper respiratory<br />

tract”<br />

247 Henrik Kolstad “Do Indoor Molds in<br />

Non-Industrial Environments Threaten<br />

Workers’ Health? A Review of the<br />

Epidemiologic Evidence”<br />

248 Koltai PJ “Effects of air pollution on the<br />

upper respiratory tract of children”<br />

21<br />

LWFR-EXP15-000859-<br />

LWFR-EXP15-000860<br />

LWFR-EXP15-000861-<br />

LWFR-EXP15-000866<br />

LWFR-EXP15-000867-<br />

LWFR-EXP15-000869<br />

LWFR-EXP15-000870-<br />

LWFR-EXP15-000873<br />

LWFR-EXP15-000874-<br />

LWFR-EXP15-000876<br />

LWFR-EXP15-000877-<br />

LWFR-EXP15-000891<br />

LWFR-EXP15-000892-<br />

LWFR-EXP15-000895<br />

249 Lab Rpt Badge 8-06-09 LWFR-EXP15-000896<br />

250 Lab Rpt Tube 8-06-09 LWFR-EXP15-000897<br />

251 Lee Ch, Maibach HI; “Study of<br />

cumulative irritant contact dermatitis in<br />

man utilizing open application on sub<br />

clinically irritated skin”<br />

LWFR-EXP15-000898-<br />

LWFR-EXP15-000903<br />

252 PR Morey PhD “Microbiological<br />

Contamination in Buildings”<br />

LWFR-EXP15-000904-<br />

LWFR-EXP15-000910<br />

253 Suzanne Gravesen “Microfungal<br />

Contamination of Damp Buildings”<br />

LWFR-EXP15-000911-<br />

LWFR-EXP15-000914<br />

254 Mold Culture Lab Rpt 8-29-09 LWFR-EXP15-000915-<br />

LWFR-EXP15-000918<br />

255 Michael C.R Alvanja “Mortality Study<br />

of Workers in Grain Industry”<br />

LWFR-EXP15-000919-<br />

LWFR-EXP15-000924<br />

256 MSDS Sheet Formaldehyde LWFR-EXP15-000925-<br />

LWFR-EXP15-000936<br />

257 Mycotoxins - Ruth A Etzel MD LWFR-EXP15-000937-<br />

LWFR-EXP15-000939<br />

258 Mycotoxins & Public Health - Malloy LWFR-EXP15-000940-<br />

CD Marr JS<br />

LWFR-EXP15-000949<br />

259 Tapani Tuomi “Mycotoxins in Crude LWFR-EXP15-000950-


Bldg Materials from Water Damaged<br />

Bldgs”<br />

260 NIOSH Criteria for a Recommended<br />

Standard - Occupational Exposure<br />

261 Sheila West “Non Viral Risk Factors for<br />

Nasopharyngeal Carci<strong>no</strong>ma in The<br />

Philippines”<br />

262 Norback, D, et al; “Asthmatic symptoms<br />

and violatile organic compounds,<br />

<strong>formaldehyde</strong> and carbon dioxide in<br />

dwellings”<br />

263 Ogunleye, et al; “Usual and unusual<br />

features of si<strong>no</strong>nasal cancer in Nigerian<br />

Africans; a prospective study of 27<br />

patients”<br />

264 Formaldehyde 2016, NIOSH Manual of<br />

Analytical Methods, Fourth Edition<br />

265 Formaldehyde by Vis 3500, NIOSH<br />

Manual of Analytical Methods, Fourth<br />

Edition<br />

266 OSHA Formaldehyde Sampling<br />

Method, Method Development Team,<br />

Industrial Hygiene Chemistry Division<br />

267 OSHA Formaldehyde Sampling Method<br />

1007, Method Development Team,<br />

Industrial Hygiene Chemistry Division<br />

268 X Weng, CH Chon, H Jiang, D Li,<br />

“Rapid Detection of Formaldehyde<br />

Concentration in Food on a<br />

Polydimethylsiloxane (PDMS)<br />

Microfluidic Chip” Food Chemistry 114<br />

(2009) 1079-1082.<br />

269 Evaluation of Formaldehyde Levels in<br />

Occupied Federal Emergency<br />

Management Agency-Owned Temporary<br />

Housing Units, National Center for<br />

Environmental Health.<br />

270 Franklin Mirer, “Risky Business:<br />

Forming Your Opinion of Katrina, Part<br />

1” The Synergist, January 2009<br />

271 LJ Salas and HB Singh, “Measurements<br />

of Formaldehyde and Acetaldehyde in<br />

the Urban Ambient Air” Atmospheric<br />

Environment Vol. 20 No. 6. (1986) pp.<br />

LWFR-EXP15-000955<br />

LWFR-EXP15-000956-<br />

LWFR-EXP15-000958<br />

LWFR-EXP15-000959-<br />

LWFR-EXP15-000965<br />

LWFR-EXP15-000966-<br />

LWFR-EXP15-000974<br />

LWFR-EXP15-000975-<br />

LWFR-EXP15-000981<br />

LWFR-EXP11-001662-<br />

LWFR-EXP11-001668<br />

LWFR-EXP11-001669-<br />

LWFR-EXP11-001673<br />

LWFR-EXP11-001691-<br />

LWFR-EXP11-001726<br />

LWFR-EXP11-001727-<br />

LWFR-EXP11-001758<br />

LWFR-EXP11-001962-<br />

LWFR-EXP11-001965.<br />

LWFR-EXP11-001926-<br />

LWFR-EXP11-001961<br />

LWFR-EXP11-001966-<br />

LWFR-EXP11-001969<br />

LWFR-EXP11-002128-<br />

LWFR-EXP11-002131<br />

22


1301-1304.<br />

272 OSHA Summary of Air and Noise<br />

Sampling Results Representing Actual<br />

or Potential Exposures for Response and<br />

Recovery Workers Involved in<br />

Hurricane Response and Recovery<br />

Activities<br />

273 DeVanny Industrial Consultants,<br />

Formaldehyde Sampling: Active and<br />

Passive Sampling Protocols March 2008<br />

274 Ohmichi, Kimihide “Formaldehyde<br />

Exposure in a Gross Anatomy<br />

Laboratory”<br />

275 Jonathan White “Oral Tolerance to<br />

Contact Allergens”<br />

276 Osguthorpe, David “Frontal Sinus<br />

Malignancies”<br />

23<br />

LWFR-EXP11-001759-<br />

LWFR-EXP11-001761<br />

LWFR-EXP11-001762-<br />

LWFR-EXP11-001890<br />

LWFR-EXP15-000982-<br />

LWFR-EXP15-000987<br />

LWFR-EXP15-000988-<br />

LWFR-EXP15-000996<br />

LWFR-EXP15-000997-<br />

LWFR-EXP15-001010<br />

277 OSHA Recognized Carci<strong>no</strong>gens LWFR-EXP15-001011-<br />

LWFR-EXP15-001012<br />

278 Michael Hodgson “Outbreak Recurrent LWFR-EXP15-001013-<br />

Chronic Hypersensitivity Pneumonitis LWFR-EXP15-001020<br />

office workers”<br />

279 B.A Owen, et al;” Formaldehyde in<br />

Drinking Water: Comparative Hazard<br />

Evaluation and an Approach to<br />

Regulation”<br />

280 Elizabeth Sherertz “Patch Testing<br />

Discordance Alert - False Negative<br />

Findings”<br />

281 Pattys Toxicology 5th Edition Volume 5<br />

- Aldehydes and Acetals<br />

282 Paustenbach, et al; “A recommended<br />

occupational exposure limit for<br />

<strong>formaldehyde</strong> based on irritation”<br />

283 Pediatrics- Toxic Effects of Indoor<br />

Molds March 2005<br />

284 Christina Scheel, et al; “Possible Sources<br />

of Sick Bldg Syndrome Tennesee<br />

Middle School”<br />

285 Paivi Rauni, et al; “Preliminary<br />

Description of Antigenic Components<br />

Characteristic”<br />

286 Michael Hodgson, et al; “Pulmonary<br />

Disease Associated with Cafeteria<br />

LWFR-EXP15-001021-<br />

LWFR-EXP15-001038<br />

LWFR-EXP15-00139-<br />

LWFR-EXP15-001040<br />

LWFR-EXP15-001041-<br />

LWFR-EXP15-001042<br />

LWFR-EXP15-001043-<br />

LWFR-EXP15-001090<br />

LWFR-EXP15-001091-<br />

LWFR-EXP15-001095<br />

LWFR-EXP15-000196-<br />

LWFR-EXP15-001100<br />

LWFR-EXP15-001101-<br />

LWFR-EXP15-001110<br />

LWFR-EXP15-001111-<br />

LWFR-EXP15-001116


Flooding”<br />

287 Tove Agner – “Formaldehye Allergy –<br />

A Follow Up Study”<br />

288 Arts – “Inhaled formaledhydeevaluation<br />

of sensory irritation in<br />

relation to carci<strong>no</strong>genicity”<br />

289 Arts – “Setting an indoor air exposure<br />

limit for <strong>formaldehyde</strong>_ Factors of<br />

concern”<br />

290 Ballarin, Cinzia – “Micronucleated Cells<br />

in Nasal Mucosa”<br />

291 Ballenger, MD, John J.– “Some Effects<br />

of Formaldehyde on the Upper<br />

Respiratory Tract”<br />

292 Barreto, Mauricio L. – “Risk Factors and<br />

Immu<strong>no</strong>logical Pathways for Asthma<br />

and Other Allergic Diseases in Children”<br />

293 Batra, Jyotsna – “Inductible Nitric Oxide<br />

Synthase”<br />

294 Berke, MD, Jerry H. – “Cytologic<br />

Examination of the Nasal Mucosa in<br />

Formaldehyde-exposed Workers”<br />

295 Bermudez – “Characterization of Cell<br />

Lines Derived from Formaldehyde-<br />

Induced Nasal Tumors in Rats”<br />

296 Blair – “Epidemiologic Evidence on the<br />

relationship between <strong>formaldehyde</strong><br />

exposure and cancer”<br />

297 Bolt – “Experimental Toxicology of<br />

Formaldehyde”<br />

298 Boysen – “Nasal Mucosa of Workers<br />

Exposed to HCHO”<br />

299 Bredt -“Endoge<strong>no</strong>us Nitric Oxide<br />

Synthesis”<br />

300 Brown, Sara J. – “Atopic Eczema and<br />

the Filaggrin Story”<br />

301 Bruynzeel – “Formaldehyde Contact<br />

Sensitivity and the use of Shampoo”<br />

302 Burgaz – “Micronuclei Frequencies in<br />

Exfoliated Nasal Mucosa Cells from<br />

Pathology and Anatomy Laboratory<br />

Workers”<br />

303 Casa<strong>no</strong>va – “Covalent Binding of<br />

Inhaled<br />

LWFR-EXP15-002179-<br />

LWFR-EXP15-002184<br />

LWFR-EXP15-002185-<br />

LWFR-EXP15-002201<br />

LWFR-EXP15-002202-<br />

LWFR-EXP15-002207<br />

LWFR-EXP15-002208-<br />

LWFR-EXP15-002214<br />

LWFR-EXP15-002215-<br />

LWFR-EXP15-002218<br />

LWFR-EXP15-002219-<br />

LWFR-EXP15-002228<br />

LWFR-EXP15-002229-<br />

LWFR-EXP15-002237<br />

LWFR-EXP15-002238-<br />

LWFR-EXP15-002242<br />

LWFR-EXP15-002243-<br />

LWFR-EXP15-002250<br />

LWFR-EXP15-002251-<br />

LWFR-EXP-002266<br />

LWFR-EXP15-000267-<br />

LWFR-EXP15-002272<br />

LWFR-EXP15-002273<br />

LWFR-EXP15-002279<br />

LWFR-EXP15-000280–<br />

LWFR-EXP15-002302<br />

LWFR-EXP15-002303-<br />

LWFR-EXP15-002313<br />

LWFR-EXP15-002314-<br />

LWFR-EXP15-002316<br />

LWFR-EXP15-002317-<br />

LWFR-EXP15-002321<br />

LWFR-EXP15-002322-<br />

LWFR-EXP15-002343<br />

24


Formaldehyde to DNA in the<br />

Respiratory<br />

Tract of Rhesus Monkeys”<br />

304 Casa<strong>no</strong>va – “DNA-Protein Cross-Links<br />

and Cell Replication at Specific Sites in<br />

the Nose of F344 Rats”<br />

305 Casarett & Doull's – Toxicology – “The<br />

Basic Science of Poisons” – Sixth<br />

Edition<br />

306 Casset – “Le Formaldehyde inhale et la<br />

response bronchique”<br />

25<br />

LWFR-EXP15-002344-<br />

LWFR-EXP15-002356<br />

LWFR-EXP15-002357-<br />

LWFR-EXP15-002358<br />

LWFR-EXP15-002359-<br />

LWFR-EXP15-002369<br />

307 Chan – “Atopic Dermatitis in 2008” LWFR-EXP15-002370-<br />

308 Chen, JJ– “Detoxification of Reactive<br />

Aldehydes in Mitochondria”<br />

309 Co<strong>no</strong>lly, Rory B. – “Human Respiratory<br />

Tract Cancer Risks of Inhaled<br />

Formaldehyde”<br />

310 Co<strong>no</strong>lly, Rory B. – “Simulation<br />

Modeling of the Tissue Disposition of<br />

Formaldehyde”<br />

311 Costa, Solange – “Ge<strong>no</strong>toxic Damage in<br />

Pathology Anatomy Laboratory Workers<br />

Exposed to Formaldehyde”<br />

312 Cronin – “Formaldehyde is a Significant<br />

Allergen in Women with Hand Eczema”<br />

313 Dales, MD, Robert– “Quality of indoor<br />

residential air and health”<br />

314 Davydov, Vadim V. – “Age-Related<br />

Changes in Activity of Enzymes<br />

Catalyzing Oxidation-Reduction”<br />

315 Davydov, Vadim V. – “Possible Role of<br />

Alteration of Aldehyde's Scavenger<br />

Enzymes During Aging”<br />

316 de Groot – “Patch Test Reactivity to<br />

DMDM Hydantoin”<br />

317 Delfi<strong>no</strong>, Ralph J.– “Asthma Symptoms<br />

in Hispanic Children and Daily Ambient<br />

Exposures to Toxic and Criteria Air<br />

Pollutants”<br />

318 Delfi<strong>no</strong>, Ralph J. – “Epidemiologic<br />

Evidence for Asthma and Exposure to<br />

Air Toxics: Linkages between<br />

Occupational, Indoor and Community<br />

LWFR-EXP15-002418<br />

LWFR-EXP15-002419-<br />

LWFR-EXP15-002427<br />

LWFR-EXP15-002428-<br />

LWFR-EXP15-002445<br />

LWFR-EXP15-002446-<br />

LWFR-EXP15-002453<br />

LWFR-EXP15-002454-<br />

LWFR-EXP15-002463<br />

LWFR-EXP15-002464-<br />

LWFR-EXP15-002470<br />

LWFR-EXP15-002471-<br />

LWFR-EXP15-002476<br />

LWFR-EXP15-002477-<br />

LWFR-EXP15-002480<br />

LWFR-EXP15-002481-<br />

LWFR-EXP15-002487<br />

LWFR-EXP15-002488–<br />

LWFR-EXP15-002493<br />

LWFR-EXP15-002494-<br />

LWFR-EXP15-002503<br />

LWFR-EXP15-002504-<br />

LWFR-EXP15-002520


Air Pollution Research”<br />

319 d'Errico – “A Case-control Study on<br />

Occupational Risk Factors for Si<strong>no</strong>-<br />

Nasal Cancer”<br />

320 Eberlein-Konig – “Influence of Airborne<br />

Nitrogen Dioxide or Formaldehyde on<br />

Parameters of Skin Function”<br />

321 Edling, C. – “Formaldehyde and the<br />

Nasal Mucosa”<br />

322 Edling, C. – “Occupational exposure to<br />

Formaldehyde and Histopathological<br />

Changes in the Nasal Mucosa”<br />

323 Edling, C. – “Occupational Exposure to<br />

Formaldehyde”<br />

324 Erdei, Esther – “Indoor Air Pollutants<br />

and Immune Biomarkers among<br />

Hungarian Asthmatic Children”<br />

325 Fischer, A. – “Clinical Standardization<br />

of the TRUE Test Formaldehyde Patch”<br />

326 Fischer , A.– “Mediators of Asthma –<br />

Nitric Oxide”<br />

327 Fleming – “Patch Testing in Discoid<br />

Eczema”<br />

328 Flyvholm – “Allergic Contact Dermatitis<br />

From Formaldehyde”<br />

329 Franklin, Peter – “Raised Exhales Nitric<br />

Oxide in Healthy Children is Associated<br />

With Domestic Formaldehyde Levels”<br />

330 Garrett, M.H. – “Errata for Increased<br />

Risk of Allergy in Children due to<br />

Formaldehyde Exposure in Homes”<br />

331 Garrett, M.H. – “Increased risk of<br />

allergy in children due to <strong>formaldehyde</strong><br />

exposure in homes”<br />

332 Giwercman, Charlotte – “Classification<br />

of Atopic Hand Eczema and the<br />

Filaggrin Mutations”<br />

333 Gu, YH – “Long-term Exposure to<br />

Gaseous Formaldehyde Promotes<br />

allergen –specific<br />

IgE-mediated Immune Responses in a<br />

Murine Model”<br />

334 Hansen, Johnnie – “Formaldehyde and<br />

cancer Morbidity among male<br />

LWFR-EXP15-002521-<br />

LWFR-EXP15-002541<br />

LWFR-EXP15-002542-<br />

LWFR-EXP15-002544<br />

LWFR-EXP15-002545-<br />

LWFR-EXP15-002546<br />

LWFR-EXP15-002547-<br />

LWFR-EXP15-002554<br />

LWFR-EXP15-002555-<br />

LWFR-EXP15-002566<br />

LWFR-EXP15-002567-<br />

LWFR-EXP15-002578<br />

LWFR-EXP15-002579-<br />

LWFR-EXP15-002587<br />

LWFR-EXP15-002588-<br />

LWFR-EXP15-002598<br />

LWFR-EXP15-002599-<br />

LWFR-EXP15-002603<br />

LWFR-EXP15-002604-<br />

LWFR-EXP15-002615<br />

LWFR-EXP15-002616-<br />

LWFR-EXP15-002618<br />

LWFR-EXP15-002619-<br />

LWFR-EXP15-002620<br />

LWFR-EXP15-002621-<br />

LWFR-EXP15-002628<br />

LWFR-EXP15-002629-<br />

LWFR-EXP15-002632<br />

LWFR-EXP15-002633-<br />

LWFR-EXP15-002640<br />

LWFR-EXP15-00264-<br />

LWFR-EXP15-002647<br />

26


employees in Denmark”<br />

335 Hauptmann, Michael – “Mortality from<br />

Lymphohemtopoietic Malignancies<br />

Among Workers in Formaldehyde<br />

Industries”<br />

336 Hauptmann, Michale –“ Mortality from<br />

Solid Cancers among Workers in<br />

Formaldehyde Industries”<br />

337 Hayes, Richard B.- “Cancer of the nasal<br />

cavity and paranasal sinuses, and<br />

<strong>formaldehyde</strong> exposure”<br />

338 Hayes, Richard B.– “Mortality of <strong>US</strong><br />

Embalmers and Funeral Directors”<br />

339 Hayes, Richard B. – “Wood Related<br />

Occupations, Wood Dust Exposure and<br />

Si<strong>no</strong>nasal Cancer”<br />

340 Held, Elisabeth – “Contact Allergy to<br />

Cosmetics: Testing with Patients’ Own<br />

Products”<br />

341 Henderson, Edward M. – “SNOR and<br />

Wheeze: The Asthma Enzyme”<br />

342 Hester, Susan D. – “Formaldehyde<br />

Inducced Gene Expression in F344 Rat<br />

Nasal Respiratory Epithelium”<br />

343 Holmstrom, M. – “Histological Changes<br />

in the Nasal Mucosa in Persons<br />

Occupationally Exposed to<br />

Formaldehyde”<br />

344 Holmstrom, M. – “Histological Changes<br />

in the Nasal Mucosa in Rats after Long<br />

Term Exposure”<br />

345 Holmstrom, M. – “Respiratory<br />

Symptoms and Pathophysiological<br />

Effects of Occupational Exposure to<br />

Formaldehyde and Wood Dust”<br />

346 Hovding – “Contact Eczema Due to<br />

Formaldehyde in Resin Finished<br />

Textiles”<br />

347 Ionescu, Jean – “Experimental Chronic<br />

Obstructive Lung Disease.<br />

Bronchopulmonary Changes Induced<br />

in Rabbits by Prolonged Exposure to<br />

Formaldehyde”<br />

27<br />

LWFR-EXP15-002648-<br />

LWFR-EXP15-002656<br />

LWFR-EXP15-002657-<br />

LWFR-EXP15-002670<br />

LWFR-EXP15-002671-<br />

LWFR-EXP15-002676<br />

LWFR-EXP15-002677-<br />

LWFR-EXP15-002688<br />

LWFR-EXP15-002689-<br />

LWFR-EXP15-002694<br />

LWFR-EXP15-002695-<br />

LWFR-EXP15-002700<br />

LWFR-EXP15-002701-<br />

LWFR-EXP15-002704<br />

LWFR-EXP15-002705-<br />

LWFR-EXP15-002717<br />

LWFR-EXP15-002718-<br />

LWFR-EXP15-002730<br />

LWFR-EXP15-002731-<br />

LWFR-EXP15-002741<br />

LWFR-EXP15-002742-<br />

LWFR-EXP15-002747<br />

LWFR-EXP15-002748-<br />

LWFR-EXP15-002755<br />

LWFR-EXP15-002756-<br />

LWFR-EXP15-002771<br />

348 Jeffery, P.K. –“ Differences and LWFR-EXP15-002772-


Similarities between Chronic<br />

Obstructive Pulmonary Disease and<br />

Asthma”<br />

349 Kamata – “Results of a 28-Month<br />

Chronic Inhalation Toxicity Study of<br />

Formaldehyde in Male Fisher – 344<br />

Rats”<br />

350 Kerns, William D.- “Carci<strong>no</strong>genicity of<br />

Formaldehyde in Rata and Mice After<br />

Long-Term Inhalation Exposure”<br />

351 Kimbell, Julia – “Correlation of<br />

Regional Formaldehyde Flux Predictions<br />

with the Distribution of Formaldehydeinduced<br />

squamous metaplasia in F344<br />

Rat Nasal Passages”<br />

352 Kimbell, Julia-“ Nasal Dosimetry of<br />

Inhaled Gases and Particles”<br />

353 Krzyza<strong>no</strong>wski, Michal – “Chronic<br />

Respiratory Effects of Indoor<br />

Formaldehyde Exposure”<br />

354 Li<strong>no</strong>s – “Leukemia and Non-Hodgkin's<br />

Lymphoma Among Embalmers and<br />

Funeral Directors”<br />

355 Luce – “Si<strong>no</strong>nasal Cancer and<br />

Occupational<br />

Exposure to Formaldehyde and Other<br />

Substances”<br />

356 Maibach, Howard – “Formaldehyde -<br />

Effects on Animal and Human Skin”<br />

357 Maronpot, R.R. – “Toxicity of<br />

Formaldehyde Vapor in B6C3F1<br />

Mice”<br />

358 Matsunaga – “Ambient Formaldehyde<br />

Levels and Allergic Disorders Among<br />

Japanese Pregnant Women”<br />

359 Maurice, F. – “Anaphylactic Shock<br />

Caused by Formaldehyde”<br />

360 McGregor, D. – “Formaldehyde and<br />

Glutaraldehyde and Nasal Cytotoxicity”<br />

361 Mi – “Current asthma and respiratory<br />

symptoms among pupils in Shanghai,<br />

China”<br />

362 Mi – “Current asthma and respiratory<br />

symptoms among pupils in Shanghai,<br />

LWFR-EXP15-002785<br />

LWFR-EXP15-002786-<br />

LWFR-EXP15-002803<br />

LWFR-EXP15-002804-<br />

LWFR-EXP15-002814<br />

LWFR-EXP15-002815-<br />

LWFR-EXP15-002825<br />

LWFR-EXP15-002826-<br />

LWFR-EXP15-002830<br />

LWFR-EXP15-002831-<br />

LWFR-EXP15-002839<br />

LWFR-EXP15-002840-<br />

LWFR-EXP15-002841<br />

LWFR-EXP15-002842-<br />

LWFR-EXP15-002850<br />

LWFR-EXP15-002851-<br />

LWFR-EXP15-002855<br />

LWFR-EXP15-002856-<br />

LWFR-EXP15-002870<br />

LWFR-EXP15-002871-<br />

LWFR-EXP15-002877<br />

LWFR-EXP15-002878-<br />

LWFR-EXP15-002879<br />

LWFR-EXP15-002880-<br />

LWFR-EXP15-002896<br />

LWFR-EXP15-002897-<br />

LWFR-EXP15-002908<br />

LWFR-EXP15-002897-<br />

LWFR-EXP15-002908<br />

28


China”<br />

363 Monticello, Thomas M.-“ Cell<br />

Proliferation and Formaldehyde-Induced<br />

Respiratory Carci<strong>no</strong>genesis”<br />

364 Monticello, Thomas M. – “Effects of<br />

Formaldehyde Gas on the Respiratory<br />

Tract of Rhesus Monkeys”<br />

365 Nederost, Susan T. – “The Role of Patch<br />

Testing for Chemical and Protein<br />

Allergens in Atopic Dermatitis”<br />

366 Nielsen, G. Damgard – “Acute Airway<br />

Effects of Formaldehyde and Ozone in<br />

BALBc Mice”<br />

367 Olsen, J. H. – “Formaldehyde and the<br />

Risk of Squamous Cell Carci<strong>no</strong>ma of the<br />

Si<strong>no</strong>nasal Cavities”<br />

368 Olsen, J.H. –“ Formaldehyde induced<br />

symptoms in day care centers”<br />

369 Olsen, J.H. – “Occupational<br />

<strong>formaldehyde</strong> exposure and increased<br />

nasal cancer risk in man”<br />

370 Olsen, J. H. – “Occupational Risks of<br />

Si<strong>no</strong>nasal Cancer in Denmark”<br />

371 Ott, M. Gerald – “Lymphatic and<br />

Hematopoietic Tissue Cancer in<br />

Chemical Manufacturing Environment”<br />

372 Parmigiani - Ethotoxicology-“An<br />

Evolutionary Approach to the Study of<br />

Environmental Endocrine-Disrupting<br />

Chemicals”<br />

373 Pati, S.-“ Indoor Environmental Risk<br />

Factors for Asthma and Respiratory Ill<br />

Health in Preschool Children”<br />

374 Patty’s Toxicology – 5 th Edition –<br />

Volume 5<br />

“Aldehydes and Acetals”<br />

375 Pazdrak, Konrad- “Changes in nasal<br />

lavage fluid due to HCHO inhalation”<br />

376 Pedersen – “Occupational Hand Eczema<br />

from Formaldehyde in Price Labels”<br />

377 Pinkerton, L.E. – “Mortality among a<br />

cohort of garment workers exposed to<br />

Formaldehyde”<br />

29<br />

LWFR-EXP15-002915-<br />

LWFR-EXP15-002922<br />

LWFR-EXP15-002923-<br />

LWFR-EXP15-002935<br />

LWFR-EXP15-002936-<br />

LWFR-EXP15-002941<br />

LWFR-EXP15-002942-<br />

LWFR-EXP15-002953<br />

LWFR-EXP15-002954-<br />

LWFR-EXP15-002960<br />

LWFR-EXP15-002961-<br />

LWFR-EXP15-002966<br />

LWFR-EXP15-002967-<br />

LWFR-EXP15-002972<br />

LWFR-EXP15-002973-<br />

LWFR-EXP15-002979<br />

LWFR-EXP15-002980-<br />

LWFR-EXP15-002992<br />

LWFR-EXP15-002993-<br />

LWFR-EXP15-003000<br />

LWFR-EXP15-003001-<br />

LWFR-EXP15-003002<br />

LWFR-EXP15-003003-<br />

LWFR-EXP15-003016<br />

LWFR-EXP15-003017-<br />

LWFR-EXP15-003021<br />

LWFR-EXP15-003022-<br />

LWFR-EXP15-003024<br />

LWFR-EXP15-003025-<br />

LWFR-EXP15-003032<br />

378 Recio, Leslie – “Oncogene and Tumor LWFR-EXP15-003033-


Supressor Gene Alterations in Nasal LWFR-EXP15-003038<br />

Tumors”<br />

379 Roitt - Immu<strong>no</strong>logy Seventh Edition LWFR-EXP15-003039-<br />

LWFR-EXP15-003040<br />

380 Rostenberg, A. – “A Study of<br />

Eczematous Sensitivity to<br />

Formaldehyde”<br />

LWFR-EXP15-003041-<br />

LWFR-EXP15-003045<br />

381 Rumchev, K.B. –“ Domestic exposure to<br />

<strong>formaldehyde</strong> significantly increases the<br />

risk of asthma in young children”<br />

382 Rusch, George M. – “A 26 Week<br />

Inhalation Toxicity Study With<br />

Formaldehyde in the Monkey, Rat and<br />

Hamster”<br />

30<br />

LWFR-EXP15-003046-<br />

LWFR-EXP15-003051<br />

LWFR-EXP15-003052-<br />

LWFR-EXP15-003066<br />

383 Shaham - DNA-Protein Cross-Links LWFR-EXP15-003067-<br />

LWFR-EXP15-003076<br />

384 Sittig, Marshall – “Handbook of Toxic<br />

and Hazardous Chemicals and<br />

Carci<strong>no</strong>gens”<br />

LWFR-EXP15-003077-<br />

LWFR-EXP15-003082<br />

385 Smedje – “Asthma among secondary<br />

schoolchildren<br />

in relation to the school environment”<br />

386 Smedje – “Incidence of Asthma<br />

Diag<strong>no</strong>sis and Self-Reported Allergy”<br />

387 Stellman, Steven D. – “Cancer Mortality<br />

and Wood Dust Exposure Among<br />

Participants In The American Cancer<br />

Society Cancer Prevention Study-II”<br />

388 Stroup, Nancy E. – “Brain Cancer and<br />

Other Causes of Death in Anatomists”<br />

389 Swenberg, James A. –“ Induction of<br />

Squamous Cell Carci<strong>no</strong>mas of the Rat<br />

Nasal Cavity”<br />

390 Takahashi, Sachiko– “Prospective Study<br />

of Clinical Symptoms and Skin Test<br />

Reactions in Medical Students”<br />

391 Tavernier, Gael - IPEADAM study –<br />

“indoor endotoxin exposure”<br />

392 Thompson – “Mechanistic and Dose<br />

Considerations for Support Adverse<br />

Pulmonary Physiology”<br />

393 Thompson – “Mechanistic<br />

Considerations for HCHO induced<br />

bronchoconstriction”<br />

LWFR-EXP15-003083-<br />

LWFR-EXP15-003092<br />

LWFR-EXP15-003093-<br />

LWFR-EXP15-003100<br />

LWFR-EXP15-003102-<br />

LWFR-EXP15-003110<br />

LWFR-EXP15-003111-<br />

LWFR-EXP15-003118<br />

LWFR-EXP15-003119-<br />

LWFR-EXP15-003123<br />

LWFR-EXP15-003124-<br />

LWFR-EXP15-003131<br />

LWFR-EXP15-003132-<br />

LWFR-EXP15-003138<br />

LWFR-EXP15-003139-<br />

LWFR-EXP15-003144<br />

LWFR-EXP15-003145-<br />

LWFR-EXP15-003150


394 Til – “Evaluation of Oral Toxicity of<br />

Acetaldehyde and Formaldehyde”<br />

395 Til – “Two-Year Drinking-Water Study<br />

of Formaldehyde in Rats”<br />

396 <strong>US</strong> DHH – “Toxicology Profile for<br />

Formaldehyde”<br />

397 <strong>US</strong> EPA – “Formaldehyde Hazard<br />

Summary”<br />

398 Vaughan – “Formaldehyde and Cancers<br />

of the Pharynx, Sinus and Nasal Cavity<br />

1”<br />

399 Vaughan – “Formaldehyde and Cancers<br />

of the Pharynx, Sinus and Nasal Cavity<br />

2”<br />

400 Vaughan – “Occupational Exposure to<br />

Formaldehyde and Wood Dust and<br />

Nasopharyngeal Carci<strong>no</strong>ma copy”<br />

401 von Bub<strong>no</strong>ff – “Dendritic Cells and<br />

Atopic Eczema-Dermatitis Syndrome”<br />

Walrath – “Motality Patterns Among<br />

Embalmers”<br />

Wantke – “Exposure to gaseous HCHO<br />

induces<br />

IgE-Mediated sensitization to HCHO”<br />

West – “Non-Viral Risk Factors for<br />

Nasopharyngeal Carci<strong>no</strong>ma in the<br />

Phillippines- Results from a Case<br />

Control Study copy”<br />

Weston – “Type IV Reactions in the<br />

Skin”<br />

Wilmer – “Subacute 4-week Inhalation<br />

Toxicity Study”<br />

Wilmer – “Subchronic 13-week<br />

Inhalation Toxicity Study of<br />

Formaldehyde in Male Rats”<br />

World Health Organization -<br />

Environmental Health Criteria –<br />

Formaldehyde<br />

World Health Organization - IARC<br />

Mo<strong>no</strong>graphs on the Evaluation of<br />

Carci<strong>no</strong>genic Risks to Humans<br />

Woutersen – “Subchronic 13-Week<br />

Inhalation Toxicity Study of<br />

LWFR-EXP15-003151-<br />

LWFR-EXP15-003158<br />

LWFR-EXP15-003159-<br />

LWFR-EXP15-003170<br />

LWFR-EXP15-003171-<br />

LWFR-EXP15-003638<br />

LWFR-EXP15-003639-<br />

LWFR-EXP15-003643<br />

LWFR-EXP15-003644-<br />

LWFR-EXP15-003650<br />

LWFR-EXP15-003651-<br />

LWFR-EXP15-003655<br />

LWFR-EXP15-003656-<br />

LWFR-EXP15-003664<br />

LWFR-EXP15-003665-<br />

LWFR-EXP15-003670<br />

LWFR-EXP15-003671–<br />

LWFR-EXP15-003676<br />

LWFR-EXP15-003677-<br />

LWFR-EXP15-003682<br />

LWFR-EXP15-003683-<br />

LWFR-EXP15-003688<br />

LWFR-EXP15-003689-<br />

LWFR-EXP15-003693<br />

LWFR-EXP15-003694-<br />

LWFR-EXP15-003697<br />

LWFR-EXP15-003698-<br />

LWFR-EXP15-003705<br />

LWFR-EXP15-003706-<br />

LWFR-EXP15-003876<br />

LWFR-EXP15-003877-<br />

LWFR-EXP15-003877<br />

LWFR-EXP15-003878-<br />

LWFR-EXP15-003886<br />

31


Formaldehyde in Rats”<br />

Wuthrich – “Atopic Eczema - Genetics<br />

or Environment”<br />

Zhao – “Asthmatic Symptoms among<br />

Pupils in Relation to Winter Indoor and<br />

Outdoor Air Pollution”<br />

Zwart – “Cytotoxic and Adaptive Effects<br />

in Rat Nasal Epithelium”<br />

02-21-1989 - Formaldehyde Standard<br />

Clarification<br />

08-07-1987 - Cancer warning labels for<br />

<strong>formaldehyde</strong> and products containing<br />

<strong>formaldehyde</strong><br />

32<br />

LWFR-EXP15-003887-<br />

LWFR-EXP15-003893<br />

LWFR-EXP15-003894-<br />

LWFR-EXP15-003902<br />

LWFR-EXP15-003903-<br />

LWFR-EXP15-003916<br />

LWFR-EXP15-003917-<br />

LWFR-EXP15-003918<br />

LWFR-EXP15-003919-<br />

LWFR-EXP15-003920<br />

29 CFR 1910.1000-END LWFR-EXP15-003921-<br />

LWFR-EXP15-003940<br />

Affidavit of Patricia Williams in the LWFR-EXP15-003941-<br />

Trial of Alana Alexander and<br />

LWFR-EXP15-003942<br />

Christopher Cooper<br />

Casual Evidence of Carci<strong>no</strong>genicity<br />

from<br />

Ge<strong>no</strong>toxicity and Cytoxicity<br />

Documentation for Immediately<br />

Dangerous<br />

to Life or Health Concentrations<br />

(IDLHs) – 50000<br />

Formaldehyde - 1910.1048<br />

Formaldehyde - 5246168-312<br />

Formaldehyde presentation<br />

demonstrative evidence<br />

Hazard Communication – 1910<br />

IARC Mo<strong>no</strong>graphs Programme on the<br />

Evaluation of Carci<strong>no</strong>genic Risks to<br />

Humans pgs 9, 11, 15-17, 23, 33<br />

Intro to 29 CFR Part 1910, Occupational<br />

Exposure to Formaldehyde<br />

List of all the times analyzed strength of<br />

association in epidemiologic studies in<br />

toxic tort litigation<br />

Medical Surveillance - Formaldehyde -<br />

1910_1048 App C<br />

NIOSH 77-126a-f<br />

LWFR-EXP15-003943-<br />

LWFR-EXP15-003943<br />

LWFR-EXP15-003944-<br />

LWFR-EXP15-003945<br />

LWFR-EXP15-003946-<br />

LWFR-EXP15-003967<br />

LWFR-EXP15-003968-<br />

LWFR-EXP15-003969<br />

LWFR-EXP15-003970-<br />

LWFR-EXP15-004019<br />

LWFR-EXP15-004020-<br />

LWFR-EXP15-004042<br />

LWFR-EXP15-004043-<br />

LWFR-EXP15-004049<br />

LWFR-EXP15-004050-<br />

LWFR-EXP15-004051<br />

LWFR-EXP15-004052-<br />

LWFR-EXP15-004053<br />

LWFR-EXP15-004054-<br />

LWFR-EXP15-004057<br />

LWFR-EXP15-004058-


NIOSH Pocket Guide to Chemical<br />

Hazards<br />

NIOSH-Respirator Use Policy for<br />

Protection<br />

Against Carci<strong>no</strong>gens<br />

Null Hypothesis Sir Ronald Fisher0001<br />

OSHA Recognized Carci<strong>no</strong>gens<br />

OSHA Safety and Health Standards 29<br />

CFR 1910<br />

Reference Guide on Epidemiology pg<br />

333 and 358<br />

Reference Guide on Toxicology pgs<br />

336-337, 378, 407-408, 415<br />

Modern Epidemiology – 2 nd Edition –<br />

Causal Interference in Epidemiology<br />

Section 6-VI_Health Effects Discussion<br />

and Determination of Final PEL<br />

Ward, Kathleen – “A Comparison of<br />

Expression of Surface – bound<br />

Immu<strong>no</strong>globulin E on Antigen –<br />

presenting cells in cutaneous tissue<br />

between patients with allergic, irritant<br />

and atopic dermatitis”<br />

Zweiman – “The Late Phase Reaction -<br />

Role of IgE, its Receptor and Cytokines”<br />

Beane Mortality From<br />

Lyphohematopoietic Malingancies<br />

Zhang - Formaldehyde exposure and<br />

leukemia<br />

Quievryn - Loss of DNA - Protein<br />

Crosslinks from Formaldehyde<br />

Hauptmann 2009 - Mortality from<br />

Lymphohematopoietic Malignancies<br />

Coglia<strong>no</strong> - Advice of Formaldehyde and<br />

Glycol Ethers<br />

Coglia<strong>no</strong> - Summary of IARC<br />

Mo<strong>no</strong>graphs on Formaldehyde<br />

Barker - DNA Protein Crosslinks<br />

Merk - Significance of Formaldehyde<br />

Induced DNA Protein Cross links<br />

33<br />

LWFR-EXP15-004234<br />

LWFR-EXP15-004235-<br />

LWFR-EXP15-004244<br />

LWFR-EXP15-004245-<br />

LWFR-EXP15-004246<br />

LWFR-EXP15-004247-<br />

LWFR-EXP15-004249<br />

LWFR-EXP15-004250-<br />

LWFR-EXP15-004251<br />

LWFR-EXP15-004252-<br />

LWFR-EXP15–004259<br />

LWFR-EXP15-004260-<br />

LWFR-EXP15-004261<br />

LWDR-EXP15-004262-<br />

LWDR-EXP15-004267<br />

LWFR-EXP15-004268-<br />

LWFR-EXP15-004269<br />

LWFR-EXP15-004270-<br />

LWFR-EXP15-004829<br />

LWFR-EXP15-004830-<br />

LWFR-EXP15-004837<br />

LWFR-EXP15-004838-<br />

LWFR-EXP15-004843<br />

LWFR-EXP15-004846-<br />

LWFR-EXP15-004865<br />

LWFR-EXP15-004866-<br />

LWFR-EXP15-004884<br />

LWFR-EXP15-004885-<br />

LWFR-EXP15-004892<br />

LWFR-EXP15-004893-<br />

LWFR-EXP15-004905<br />

LWFR-EXP15-004906-<br />

LWFR-EXP15-004906<br />

LWFR-EXP15-004907-<br />

LWFR-EXP15-004911<br />

LWFR-EXP15-004912-<br />

LWFR-EXP15-004937<br />

LWFR-EXP15-004938-<br />

LWFR-EXP15-004947


Wright Trial Power point demonstrative<br />

evidence Chart on Formaldehyde<br />

concentrations and eczema<br />

Chart on Formaldehyde concentrations<br />

and cancers<br />

Chart on Formaldehyde concentrations<br />

and Ge<strong>no</strong>toxicity and Cytotoxicity<br />

Report of Patricia M. Williams PhD,<br />

DABT on Lyndon Wright<br />

Charts on error rate/false positives/false<br />

negatives of TRUE Test<br />

Chart on Reproducibility of TRUE Test<br />

results<br />

Diagram of chemical reactions in TRUE<br />

Test<br />

Chart on OSHA and gaseous<br />

Formaldehyde and eczema and cancer<br />

Chart on Scientific Literature and<br />

Cancers and Formaldehyde<br />

Chart on Sensitive Populations<br />

Chart on ATSDR Minimal Risk Levels<br />

Chart on Scientific Methodology<br />

Chart on DNA damage and<br />

consequences to the cell<br />

Chart on epidemiologic flaws of Cohort<br />

studies vs Case studies<br />

Reference Manual Scientific Evidence,<br />

2 nd Edition (2000)<br />

Gollhausen, et al., Reproducibility of<br />

Patch Test results- Comparison of TRUE<br />

Test, Journal of American Academy of<br />

Dermatology, 1989<br />

Dales, et al., Respiratory Health Effects<br />

of Home Dampness and Molds among<br />

Canadian Children, American Journal of<br />

Epidemiology, 1991.<br />

Riddle, HF, Prevalence of Respiratory<br />

Respiratory Symptoms and Sensitization<br />

by Mould Antigens among a group of<br />

Maltworkers, Brit. Journal of Ind. Med.<br />

(1974)<br />

Revankar, S, Clinical Implications of<br />

Mycotoxins and Stachybotrys,<br />

Southwestern Internal Medicine Conf.<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

LWFR-EXP 15-001117-<br />

LWFR-EXP15-001763<br />

LWFR-EXP 15-001764-<br />

LWFR-EXP15-001768<br />

LWFR-EXP 15-001769-<br />

LWFR-EXP15-001776<br />

LWFR-EXP 15-001777-<br />

LWFR-EXP15-001782<br />

LWFR-EXP 15-001783-<br />

LWFR-EXP15-001796<br />

34


(2003)<br />

Hendry, et al., Review of Mycotoxins in<br />

Indoor Air, Journal of Toxicology and<br />

Env. Science (1993)<br />

Zachariae, et al., ROAT- Mophology of<br />

Roat on Arm, Neck and Face in<br />

<strong>formaldehyde</strong> and diazolidinyl urea<br />

sensitive individuals, Contact Dermatitis<br />

(2006)<br />

Simon, Textbook of Forensic<br />

Psychiatry, American Psychiatric<br />

Publishing, Inc., Washington DC, 2004<br />

Leung, Donald YM, Role of IGE in<br />

Atopic Dermatitis, Current Opinions in<br />

immu<strong>no</strong>logy (1993)<br />

Rumchev, et al, Association of domestic<br />

exposure to volatile organic compounds<br />

with asthma in young children<br />

Rumchev, et al, Domestic Exposure to<br />

Formaldehyde significantly increases<br />

the risk of asthma in young children, Eur<br />

Respir J (2002)<br />

Ruoppi, et al., Nasal symptoms among<br />

residents in moldy housing, Scand. J.<br />

Work Environ Health (2003)<br />

Schacter, et al., A Study of Respiratory<br />

Effects from Exposure to 2.0 ppm<br />

Formaldehyde in Occupationally<br />

Exposed Workers, Environmental<br />

Research (1987)<br />

Scheynius, et al., Absence of specific IgE<br />

antibodies in allergic contact sensitivity<br />

to <strong>formaldehyde</strong>, Allergy (1993)<br />

Schnuch, et al., Quantitative patch and<br />

repeated open application testing in<br />

hydroxyisohexyl 3-cyclohexene<br />

carbohaldehyde sensitive-patients,<br />

Contact Dermatitis (2009)<br />

Sciandra, et al., Pleomorphic ade<strong>no</strong>ma<br />

of the lateral nasal wall: case report,<br />

Acta Otorhi<strong>no</strong>laryngologica (2008)<br />

Shin, et al., Chronic Rhi<strong>no</strong>sinustis: An<br />

enhanced immune response to<br />

ubiquitous airborne fungi, Journal of<br />

LWFR-EXP 15-001797-<br />

LWFR-EXP15-001812<br />

LWFR-EXP 15-001813-<br />

LWFR-EXP15-001817<br />

LWFR-GEN-000003 –<br />

LWFR-GEN-000014<br />

LWFR-EXP 15-001818-<br />

LWFR-EXP15-001824<br />

LWFR-EXP 15-001825-<br />

LWFR-EXP15-001832<br />

LWFR-EXP 15-001833-<br />

LWFR-EXP15-001838<br />

LWFR-EXP 15-001839-<br />

LWFR-EXP15-001846<br />

LWFR-EXP 15-001847-<br />

LWFR-EXP15-001867<br />

LWFR-EXP 15-001868-<br />

LWFR-EXP15-00<strong>1873</strong><br />

LWFR-EXP 15-001874-<br />

LWFR-EXP15-001885<br />

LWFR-EXP 15-001886-<br />

LWFR-EXP15-001889<br />

LWFR-EXP 15-001890-<br />

LWFR-EXP15-001897<br />

35


allergy and clinical immu<strong>no</strong>logy (2004)<br />

Shio<strong>no</strong>, Mutomi, Surgery for acute<br />

aortic dissection using gelatinresourcin-formalin<br />

glue, J. Artif. Organs<br />

(2008)<br />

Simoni, et al., Mould/dampness<br />

exposure at home is associated with<br />

respiratory disorders in Italian Children<br />

and adolescents, (2005)<br />

Yuotunde, et al., Si<strong>no</strong>nasal<br />

Malignancies: A 10-Year Review in a<br />

Tertiary Health Institution, Journal of<br />

the National Medical Association (2007)<br />

Skorge, et al., Indoor exposures and<br />

respiratory symptoms in a Norwegian<br />

community sample, Thorax (2004)<br />

Kwon, et al., Sooty Mold of Persimmon-<br />

Caused by Cladosporium cladospioides,<br />

Plant Pathol. J. (2003)<br />

Sosrose<strong>no</strong>, Wihaskoro, A review of the<br />

mechanisms of oral tolerance and<br />

immu<strong>no</strong>therapy, Journal of the Society<br />

of Medicine (1995)<br />

Speit, et al., The Human Lung Cell Line<br />

A549 Does Not Develop Adaptive<br />

Protection Against the DNA-Damaging<br />

Action of Formaldehyde, Env. And<br />

Molecular Mutogenes (2009)<br />

Takahashi, et al., Prospective study of<br />

clinical symptoms and skin test reactions<br />

in medical students exposed to<br />

<strong>formaldehyde</strong> gas, Japanese<br />

Dermatological Association (2007)<br />

Takigawa, et al., Reduction of Indoor<br />

Formaldehyde Concentrations and<br />

Subjective Symptoms in a Gross<br />

Anatomy Laboratory, Bull. Environ.<br />

Contam. Toxicol (2005)<br />

Fisher, Ronald A., The Design of<br />

Experiments, Harper Publishing<br />

Toomarian, et al., Histopathological<br />

evaluation of pulpotomy, Lasers Med.<br />

Sci. (2008)<br />

36<br />

LWFR-EXP15-001898-<br />

LWFR-EXP15-001902<br />

LWFR-EXP 15-001908-<br />

LWFR-EXP15-001916<br />

LWFR-EXP 15-001917-<br />

LWFR-EXP15-001920<br />

LWFR-EXP 15-001921-<br />

LWFR-EXP15-001928<br />

LWFR-EXP 15-001929-<br />

LWFR-EXP15-001931<br />

LWFR-EXP 15-001332-<br />

LWRF-EXP15-001936<br />

LWFR-EXP 15-001944-<br />

LWFR-EXP15-001951<br />

LWFR-EXP 15-001952-<br />

LWFR-EXP15-001959<br />

LWFR-EXP 15-001968-<br />

LWFR-EXP15-001971<br />

LWFR-EXP 15-001972-<br />

LWFR-EXP15-001973<br />

LWFR-EXP 15-001974-<br />

LWFR-EXP15-001981<br />

Tortorici, et al., Maxillary bone necrosis LWFR-EXP 15-001982-


following the use of <strong>formaldehyde</strong><br />

containing paste: management and case<br />

series, British Dental Journal (2007)<br />

Towers, et al., Maxillary sinusitis<br />

mimicking malignant disease, Oral.<br />

Surg. (1975)<br />

Jarvis, et al., Toxigenic Molds in Water<br />

Damaged Buildings, Journal of Nat.<br />

Prod. (1996)<br />

Sorenson, et al., Trichothecene<br />

Mycotoxins in Aerosolized- Conidia of<br />

Stachyboltrys Atra, Applied and<br />

Environ. Microbiology (1987)<br />

Fisher, et al., Fundamentals of<br />

Diag<strong>no</strong>stic Mycology, 1996<br />

Uba, et al., Prospective Study of<br />

Respiratory Effects of Formaldehyde<br />

Among Healthy and Asthmatic Medical<br />

Students, Am. Journal of Ind. Med.<br />

(1989)<br />

Ue<strong>no</strong>, Yoshio, The Toxicology of<br />

Mycotoxins, Critical Reviews in<br />

Toxicology<br />

Ue<strong>no</strong>, Yoshio, Trichothecenes Overview<br />

Address<br />

Van Hoogstraten, et al., Persistent<br />

Immune Tolerance to Nickel and<br />

Chromium by Oral Administration Prior<br />

to Cutaneous Sensitization, Journal of<br />

Investigative Dermatology (1992)<br />

Venn, et al., Effects of volatile organic<br />

compounds, damp, and and other<br />

environmental exposures in the home on<br />

wheezing illness in children, Thorax<br />

(2003)<br />

Vilarma and Maibach, Correlations of<br />

patch test reactivity and the repeated<br />

open application test<br />

(ROAT)/provocative use test (PUT),<br />

Food and Chemical Toxicology (2004)<br />

Vimpel, et al., The value of X-ray<br />

examination of the paranasal sinuses<br />

after epistaxis, Journal of Laryngology<br />

and Otology (1985)<br />

LWFR-EXP15-001984<br />

LWFR-EXP 15-001985-<br />

LWFR-EXP15-001991<br />

LWFR-EXP 15-001992-<br />

LWFR-EXP15-001993<br />

LWFR-EXP 15-001994-<br />

LWFR-EXP15-001999<br />

LWFR-EXP 15-002000-<br />

LWFR-EXP15-002003<br />

LWFR-EXP 15-002004-<br />

LWFR-EXP15-002015<br />

LWFR-EXP 15-002016-<br />

LWFR-EXP15-002049<br />

LWFR-EXP 15-002050-<br />

LWFR-EXP15-002060<br />

LWFR-EXP 15-002061-<br />

LWFR-EXP15-002071<br />

LWFR-EXP 15-002072-<br />

LWFR-EXP15-002079<br />

LWFR-EXP 15-002080-<br />

LWFR-EXP15-002087<br />

LWFR-EXP 15-002088-<br />

LWFR-EXP15-002094<br />

37


Von Bub<strong>no</strong>ff, et al., Dendric cells and<br />

atopic eczema/dermatitis syndrome, Skin<br />

and Eye<br />

Wahlberg, et al., Quantification and<br />

Specificity of the Repeated Open<br />

Application Test (ROAT), Acta Derm<br />

Venereol (1997)<br />

Wantke, et al., Formaldehyde and<br />

phe<strong>no</strong>l exposure during an anatomy<br />

dissection course: A possible source of<br />

IgE sensitization, Allergy (1996)<br />

Wantke, et al., Exposure to<br />

<strong>formaldehyde</strong> and phe<strong>no</strong>l during an<br />

dissecting course: sensitizing potency of<br />

<strong>formaldehyde</strong> in medical students,<br />

Allergy (2000)<br />

Wantke, et al., Exposure to<br />

<strong>formaldehyde</strong> and phe<strong>no</strong>l during<br />

anatomy dissecting course: sensitizing<br />

potency of <strong>formaldehyde</strong> in medical<br />

students, Allergy (2000)<br />

Ward, et al., A comparison of expression<br />

of surface-bound immu<strong>no</strong>globulin E on<br />

antigen-presenting cells in cutaneous<br />

tissue between patients with allergic,<br />

irritant and atopic dermatitis, Contact<br />

Dermatitis (1991)<br />

White, et al., Oral Tolerance to contact<br />

allergens: a common occurrence? A<br />

review, Contact Dermatitis (2007)<br />

Zaghi and Maibach, Quantitative<br />

Relationships Between Patch Test<br />

Reactivity and Use Test Reactivity: An<br />

Overview, Cutaneous and Ocular<br />

Toxicology (2008)<br />

Ziem and McTamney, Profile of Patients<br />

with Chemical Injury and Sensitivity,<br />

Environmental Health Perspectives<br />

(1997)<br />

Gibson, James, Formaldehdye Toxicity,<br />

(1983)<br />

88. Any and all articles identified and/or<br />

relied upon by Plaintiff and/or<br />

Defendant experts in the preparation of<br />

LWFR-EXP 15-002095-<br />

LWFR-EXP15-002100<br />

LWFR-EXP 15-002101-<br />

LWFR-EXP15-002106<br />

LWFR-EXP 15-002107-<br />

LWFR-EXP15-002112<br />

LWFR-EXP 15-002113-<br />

LWFR-EXP15-002117<br />

LWFR-EXP 15-002118-<br />

LWFR-EXP15-002122<br />

LWFR-EXP 15-002123-<br />

LWFR-EXP15-002130<br />

LWFR-EXP 15-002137-<br />

LWFR-EXP15-002145<br />

LWFR-EXP 15-002151-<br />

LWFR-EXP15-002160<br />

LWFR-EXP 15-002161-<br />

LWFR-EXP15-002176<br />

LWFR-EXP 15-002177-<br />

LWFR-EXP15-002178<br />

To be supplemented<br />

38


their reports.<br />

Expert<br />

Records and<br />

Files<br />

89. Affidavit and Weather Data of Lee E. LWFR-EXP1-000001 –<br />

Branscome, Ph.D., C.C.M.<br />

LWFR-EXP1-000122<br />

90. Curriculum Vitae of Lee E. Branscome,<br />

Ph.D., C.C.M.<br />

PSC 025205-<br />

PSC 025214<br />

92. Medical Records of Lyndon Wright and<br />

file of George Farber, M.D.<br />

LWFR-EXP2-000021 –<br />

LWFR-EXP2-000052<br />

93. Preliminary Report of Paul Hewett,<br />

Ph.D.<br />

LWFR-EXP3-000001 –<br />

LWFR-EXP3-000026<br />

Final Report of Paul Hewett, Ph.D. LWFR-EXP2-000027-<br />

LWFR-EXP2-000060<br />

Supplemental Report of Paul Hewitt, To be supplemented<br />

Ph.D. (to be produced)<br />

94. Curriculum Vitae of Paul Hewitt, Ph.D. PSC 025265-<br />

PSC 025269<br />

Paul Hewett August 20, 2008 Technical LWFR-EXP3-000170-<br />

Report in FEMA Formaldehyde LWFR-EXP3-000197<br />

Products Liability Litigation<br />

Paul Hewett Report for Gulf Stream / LWFR-EXP3-000198-<br />

Alexander Trial<br />

Letter from FEMA to Trailer Occupants<br />

Re: Formaldehyde levels found in their<br />

<strong>trailer</strong>s<br />

39<br />

LWFR-EXP3-000216<br />

PSC 019684-<br />

PSC 019692<br />

96. Deposition Testimony of Paul Hewett, To be supplemented<br />

Ph.D.<br />

98. Preliminary Report of Kenneth LWFR-EXP6-000001-<br />

Laughery, Ph.D.<br />

LWFR-EXP6-000006<br />

Final Report of Kenneth Laughery,<br />

Ph.D.<br />

LWFR-EXP6-000007-<br />

LWFR-EXP6-000013<br />

99. Curriculum Vitae of Kenneth Laughery,<br />

Ph.D.<br />

PSC 025282-<br />

PSC 025313<br />

103. Preliminary Report of Alexis Mallet, Jr. LWFR-EXP7-000001-<br />

LWFR-EXP7-000013<br />

Final Report of Alexis Mallet, Jr. LWFR-EXP7-000014-<br />

LWFR-EXP7-000144<br />

Photographs for Report of Alexis Mallet,<br />

Jr.<br />

LWFR-EXP7-000145-<br />

LWFR-EXP7-000184<br />

104. Curriculum Vitae of Alexis Mallet, Jr. PSC 025314-<br />

PSC 025324<br />

Alexis Mallet, Jr., emails re discussion LWFR-EXP7-009495-<br />

of Parish Permit<br />

LWFR-EXP7-009497


Alexis Mallet, Jr., emails re Newspaper<br />

Article on Orleans Parish Electrical<br />

Codes<br />

Letter from Blanco to Thomas, 09/23/05<br />

Alexis Mallet emails and attached letters<br />

concerning Permit Regulations in<br />

Orleans Parish<br />

Policies and Code Clarifications<br />

Shaw Daily Quality Control Report,<br />

11/29/05<br />

Shaw emails regarding Orleans Parish<br />

Permit and Code Requirements<br />

Mach 15 RV Air Condition<br />

RVP Installation Instructions for 8000<br />

Series Air Conditioners<br />

RVP Operation and Maintenance<br />

Instructions for 6000, 7000, and 8000<br />

Series Air Conditioners<br />

RVP Data Inquiry Sheet<br />

FEMA-Dubuclet Report 7/14/09<br />

Email from Wyatt Rankin to Alex<br />

Mallet, 5/19/09<br />

Bayseal CC<br />

Bayseal CC for Residential Builders<br />

Chemical Design, Closed Cell Spray<br />

Foam<br />

Green Home Builder Creates<br />

Environmentally Friendly Home with<br />

Closed Cell Foam<br />

EnviroFoam Insulation<br />

Dometic Installation Instructions<br />

Forest River Appliance Information<br />

Sheet<br />

Emails regarding Fluor Jacking<br />

Instructions<br />

40<br />

LWFR-EXP7-009503-<br />

LWFR-EXP7-009526<br />

LWFR-EXP7-009527-<br />

LWFR-EXP7-009545<br />

LWFR-EXP7-009503-<br />

LWFR-EXP7-009526<br />

LWFR-EXP7-009546-<br />

LWFR-EXP7-009547<br />

LWFR-EXP7-009548-<br />

LWFR-EXP7-009551<br />

LWFR-EXP7-009552<br />

LWFR-EXP7-009553-<br />

LWFR-EXP7-009554<br />

LWFR-EXP7-009555-<br />

LWFR-EXP7-009570<br />

LWFR-EXP7-009571-<br />

LWFR-EXP7-009578<br />

LWFR-EXP7-009579-<br />

LWFR-EXP7-009580<br />

LWFR-EXP7-009581-<br />

LWFR-EXP7-009582<br />

LWFR-EXP7-009602<br />

LWFR-EXP7-009603-<br />

LWFR-EXP7-009604<br />

LWFR-EXP7-009605-<br />

LWFR-EXP7-009606<br />

LWFR-EXP7-009607-<br />

LWFR-EXP7-009611<br />

LWFR-EXP7-009612-<br />

LWFR-EXP7-009613<br />

LWFR-EXP7-009614-<br />

LWFR-EXP7-009621<br />

LWFR-EXP7-009583-<br />

LWFR-EXP7-009601<br />

LWFR-EXP7-009614-<br />

LWFR-EXP7-009622<br />

LWFR-EXP7-009643-<br />

LWFR-EXP7-009644


Fluor FEMA Procedures<br />

LWFR-EXP7-009645-<br />

LWFR-EXP7-009655<br />

Important Information for Travel Trailer<br />

Occupants<br />

LWFR-EXP7-009656-<br />

LWFR-EXP7-009657<br />

Formaldehyde Levels in FEMA- LWFR-EXP7-009658-<br />

Supplied Trailers<br />

LWFR-EXP7-009659<br />

Suburban Gas Furnaces Installation LWFR-EXP7-009660-<br />

Instruction<br />

LWFR-EXP7-009688<br />

Emails regarding CH20 Information LWFR-EXP7-009689<br />

Information from Composite Panel LWFR-EXP7-009690-<br />

Association Website<br />

LWFR-EXP7-009708<br />

Maxx Fan Installation Instructions LWFR-EXP7-009709-<br />

LWFR-EXP7-009713<br />

Emails regarding Closed Cell Foam LWFR-EXP7-009714-<br />

LWFR-EXP7-009717<br />

Versi-Foam Systems<br />

LWFR-EXP7-009718-<br />

LWFR-EXP7-009732<br />

Chemical Design Product Catalog: LWFR-EXP7-009733-<br />

Closed Cell Spray Foam<br />

LWFR-EXP7-009747<br />

Tool Box Training: Proper Jacking LWFR-EXP7-009748<br />

Techniques<br />

Emails Regarding Shaw Jacking LWFR-EXP7-009749-<br />

Procedure<br />

LWFR-EXP7-009750<br />

MHRA Website on Moisture Field<br />

Study<br />

LWFR-EXP7-009751-<br />

LWFR-EXP7-009752<br />

MHRA Minimizing Moisture Problems LWFR-EXP7-009753-<br />

Report<br />

LWFR-EXP7-009799<br />

MHRA Report Page with Handwritten LWFR-EXP7-009800-<br />

Note<br />

LWFR-EXP7-009801<br />

Building your Louisiana House LWFR-EXP7-009802-<br />

LWFR-EXP7-009804<br />

Email regarding Gulf Stream Coach<br />

Construction<br />

LWFR-EXP7-009805-<br />

LWFR-EXP7-009806<br />

RESNET Standards Chapter Seven LWFR-EXP7-009850-<br />

LWFR-EXP7-009877<br />

RESNET National Home Energy Rating<br />

Technical Guidelines 12/28/05<br />

LWFR-EXP7-009878-<br />

LWFR-EXP7-009918<br />

Performance Work Statement: LWFR-EXP7-009927-<br />

Individual Assistance-Technical LWFR-EXP7-009945<br />

Assistance Contract<br />

Email from Alexis Mallet to Alexis LWFR-EXP7-009958-<br />

Mallet regarding Electronic Code of LWFR-EXP7-009959<br />

Federal Regulations<br />

Stephen Patterson and Madan Mahta, LWFR-EXP7-009960-<br />

41


Roofing Design and Practice<br />

Email from Orleans Parish re: Code<br />

Enforcement<br />

106. Trailer drawings by Alexis Mallet,<br />

Jr./Ervin Ritter<br />

Trailer Photographs by Alexis Mallet, Jr.<br />

Trailer Videos by Alexis Mallet, Jr.<br />

Trailer Images by Alexis Mallet, Jr.<br />

Data Logger Information by Alexis<br />

Mallet, Jr.<br />

42<br />

LWFR-EXP7-009962<br />

LWFR-EXP7-13951<br />

LWFR-EXP7-13933-<br />

LWFR-EXP7-13950<br />

LWFR-EXP7-004671-<br />

LWFR-EXP7-005396;<br />

LWFR-EXP7-005401-<br />

LWFR-EXP7-005513;<br />

LWFR-EXP7-005518-<br />

LWFR-EXP7-005546;<br />

LWFR-EXP7-005554-<br />

LWFR-EXP7-005571;<br />

LWFR-EXP7-005574-<br />

LWFR-EXP7-005725;<br />

LWFR-EXP7-005726-<br />

LWFR-EXP7-006465;<br />

LWFR-EXP7-010628-<br />

LWFR-EXP7-010942;<br />

LWFR-EXP7-010999-<br />

LWFR-EXP7-011539;<br />

LWFR-EXP7-011541-<br />

LWFR-EXP7-011629;<br />

LWFR-EXP7-011660-<br />

LWFR-EXP7-011661;<br />

LWFR-EXP7-011749-<br />

LWFR-EXP7-011816;<br />

LWFR-EXP7-011822-<br />

LWFR-EXP7-012292;<br />

LWFR-EXP7-012782-<br />

LWFR-EXP7-013440;<br />

LWFR-EXP7-013441-<br />

LWFR-EXP7-013932<br />

LWFR-EXP7-005397;<br />

LWFR-EXP7-005398;<br />

LWFR-EXP7-005399;<br />

LWFR-EXP7-005400;<br />

LWFR-EXP7-008043-<br />

LWFR-EXP7-009430<br />

1 LWFR-EXP7-012293-<br />

1 LWFR-EXP7-012370;<br />

2 LWFR-EXP7-012371-<br />

2 LWFR-EXP7-012448;<br />

3 LWFR-EXP7-012449-<br />

3 LWFR-EXP7-012522;


4 LWFR-EXP7-012523-<br />

4 LWFR-EXP7-012600;<br />

5 LWFR-EXP7-012601-<br />

5 LWFR-EXP7-012678;<br />

6 LWFR-EXP7-012679-<br />

6 LWFR-EXP7-012756<br />

Ritter Consulting Engineers Handwritten<br />

Notes<br />

LWFR-EXP7-011817-<br />

LWFR-EXP7-011821<br />

109. Preliminary Report of Lawrence G.<br />

Miller, M.D., M.P.H.<br />

LWFR-EXP8-000001-<br />

LWFR-EXP8-000009<br />

Final Report of Lawrence G. Miller, LWFR-EXP8-000010<br />

M.D., M.P.H.<br />

LWFR-EXP8-000019<br />

Supplemental Report of Lawrence G. LWFR-EXP8-000108-<br />

Miller, M.D., M.P.H.<br />

LWFR-EXP8-000109<br />

110. Curriculum Vitae of Lawrence G.<br />

Miller, M.D., M.P.H.<br />

PSC 025360-<br />

PSC 025375<br />

Temporary Medical License for Dr. To be supplemented<br />

Lawrence Miller<br />

113. Exhibits from the deposition of To be supplemented<br />

Lawrence G. Miller, M.D., M.P.H.<br />

114. Preliminary Report of Charles David LWFR-EXP9-000001-<br />

Moore, P.E. P.L.S.<br />

LWFR-EXP9-000004<br />

Final Report of Charles David Moore, LWFR-EXP5-000005-<br />

P.E. P.L.S.<br />

LWFR-EXP5-000042<br />

115. Curriculum Vitae of Charles David<br />

Moore, P.E. P.L.S.<br />

PSC 025346-<br />

PSC 025349<br />

Construction Manuals (Manual of Steel LWFR-EXP5-000457-<br />

Construction, Minimum Design Loads, LWFR-EXP5-000459<br />

Timber Construction Manual)<br />

119. Preliminary Report of Ervin Ritter, P.E. LWFR-EXP10-000001-<br />

LWFR-EXP10-000007<br />

Final Report of Ervin Ritter, P.E. LWFR-EXP10-000008-<br />

LWFR-EXP10-000117<br />

120. Curriculum Vitae of Ervin Ritter, P.E. PSC 025350-<br />

PSC 025354<br />

121. Reliance Materials and File of Ervin To be supplemented<br />

Ritter, P.E.<br />

122. Deposition Testimony of Ervin Ritter, To be supplemented<br />

P.E.<br />

123. Exhibits from the deposition of Ervin To be supplemented<br />

Ritter, P.E.<br />

All photographs by Ervin Ritter LWFR-EXP10-000118-<br />

LWFR-EXP10-002068<br />

124. Preliminary Report of William D. Scott, LWFR-EXP11-000001-<br />

43


P.E., C.H.M.M.<br />

LWFR-EXP11-000042<br />

Final Report of William D. Scott, P.E., LWFR-EXP11-000043-<br />

C.H.M.M.<br />

LWFR-EXP11-000135<br />

125. Curriculum Vitae of William D. Scott, PSC 025355-<br />

P.E., C.H.M.M.<br />

PSC 025368<br />

126. Reliance Materials and File of William To be supplemented<br />

D. Scott, P.E., C.H.M.M.<br />

127. Deposition Testimony of William D. To be supplemented<br />

Scott, P.E. C.H.M.M.<br />

128. Exhibits from the deposition of William To be supplemented<br />

D. Scott, P.E., C.H.M.M.<br />

129. Microbial Growth Report by W.D. Scott To be supplemented<br />

and Associates<br />

130. Preliminary Report of Edward H. LWFR-EXP12-000001-<br />

Shwery, Ph.D.<br />

LWFR-EXP12-000011<br />

Preliminary Report of Edward H. LWFR-EXP12-000012-<br />

Shwery, Ph.D.<br />

LWFR-EXP12-000016<br />

131. Curriculum Vitae of Edward H. Shwery,<br />

Ph.D.<br />

PSC 025369-<br />

PSC 025391<br />

Edward H. Shwery Testing Raw Data LWFR-EXP12-000061-<br />

and Notes<br />

LWFR-EXP12-000128<br />

132. Reliance Materials and File of Edward To be supplemented<br />

H. Shwery, Ph.D.<br />

133. Deposition Testimony of Edward H. To be supplemented<br />

Shwery, Ph.D.<br />

134. Exhibits from the deposition of Edward To be supplemented<br />

H. Shwery, Ph.D.<br />

135. Preliminary Report of Stephen Smulski,<br />

Ph.D.<br />

LWFR-EXP13-000001-<br />

LWFR-EXP13-000022<br />

Final Report of Stephen Smulski, Ph.D. LWFR-EXP13-000023-<br />

LWFR-EXP13-000061<br />

136. Curriculum Vitae of Stephen Smulski, PSC 025392-<br />

Ph.D.<br />

PSC 025406<br />

Emails between Stephen Smulski and To be supplemented<br />

Composite Panel Association<br />

137. Reliance Materials and File of Stephen To be supplemented<br />

Smulski, Ph.D.<br />

Additional Reliance Documents, <strong>no</strong>t yet To be supplemented<br />

produced by Stephen Smulski, Ph.D.<br />

Photographs by Stephen Smulski, Ph.D. LWFR-EXP13-004164<br />

LWFR-EXP13-004354<br />

138. Deposition Testimony of Stephen To be supplemented<br />

Smulski, Ph.D.<br />

139. Exhibits from the deposition of Stephen To be supplemented<br />

44


Smulski, Ph.D.<br />

140. Preliminary Report of Patricia M. LWFR-EXP15-000001-<br />

Williams, Ph.D. D.A.B.T.<br />

LWFR-EXP15-000054<br />

Final Report of Patricia M. Williams, LWFR-EXP15-000055-<br />

Ph.D., D.A.B.T.<br />

LWFR-EXP15-000130<br />

141. Curriculum Vitae of Patricia M. PSC 025407-<br />

Williams, Ph.D., D.A.B.T.<br />

PSC 025437<br />

Fee Schedule of Patricia M. Williams, PSC 025438<br />

Ph.D., D.A.B.T.<br />

List of Testimonies of Patricia M.<br />

Williams, Ph.D., D.A.B.T.<br />

PSC 025439-<br />

PSC 025440<br />

142. Reliance Material and File of Patricia M. To be supplemented<br />

Williams, Ph.D., D.A.B.T.<br />

143. Deposition Testimony of Patricia M. To be supplemented<br />

Williams, Ph.D., D.A.B.T.<br />

144. Exhibits from the deposition of Patricia To be supplemented<br />

M. Williams, Ph.D., D.A.B.T.<br />

145. Preliminary Report of Paul LaGrange LWFR-EXP5-000001-<br />

LWFR-EXP5-000002<br />

Final Report of Paul LaGrange<br />

LWFR-EXP5-000003-<br />

LWFR-EXP5-000316<br />

Supplemental Report of Paul LaGrange To be supplemented<br />

146. Curriculum Vitae of Paul LaGrange PSC 026031-<br />

PSC 026034<br />

Fee Schedule of Paul LaGrange PSC 026035<br />

List of Testimonies of Paul LaGrange PSC 026036<br />

147. Reliance Materials and File of Paul To be supplemented<br />

LaGrange<br />

Additional Documents of Paul LaGrange LWFR-EXP5-000317-<br />

LWFR-EXP5-000570<br />

Photographs by Paul LaGrange LWFR-EXP5-000595-<br />

LWFR-EXP5-001243;<br />

LWFR-EXP5-001244-<br />

LWFR-EXP5-001271<br />

Videos by Paul LaGrange<br />

LWFR-EXP5-000572;<br />

LWFR-EXP5-000575;<br />

LWFR-EXP5-000573;<br />

LWFR-EXP5-000574;<br />

LWFR-EXP5-000578<br />

Initial Place Holding Report<br />

LWFR-EXP5-000576-<br />

LWFR-EXP5-000577<br />

Paul LaGrange Handwritten Notes; LWFR-EXP5-000579-<br />

Inspection Notes<br />

LWFR-EXP5-000594<br />

LaGrange Report LWFR-EXP 5-000001 –<br />

45


LWFR-EXP 5-000316;<br />

PSC 026031 –<br />

PSC 026036<br />

Dometic Installation Instructions FR-LTW-EXP06-107751<br />

–<br />

FR-LTW-EXP06-107769<br />

LaGrange Video Animation with You LWFR-EXP 5-001277<br />

Tube link<br />

LaGrange HVAC Load Calculations<br />

(Corrected Manual J Load)<br />

LWFR-EXP 5-001278 –<br />

LWFR-EXP 5-001296<br />

LaGrange Supplemental Letter of<br />

Clarification<br />

LWFR-EXP 5-001272 –<br />

LWFR-EXP 5-001273<br />

LaGrange Tectite Blower Door Test<br />

Report<br />

LWFR-EXP 5-001274 –<br />

LWFR-EXP 5-001276<br />

148. Deposition Testimony of Paul LaGrange To be supplemented<br />

149. Exhibits from the deposition of Paul To be supplemented<br />

LaGrange<br />

150. Preliminary Report of Dr. Richard A LWFR-EXP14-000001-<br />

Spector<br />

LWFR-EXP14-000004<br />

Final Report of Dr. Richard A. Spector LWFR-EXP14-000005-<br />

LWFR-EXP14-000015<br />

151. Curriculum Vitae of Dr. Richard A. PSC 026027-<br />

Spector<br />

PSC 026030<br />

152. Reliance Materials and File of Dr. To be supplemented<br />

Richard A. Spector<br />

153. Deposition Testimony of Dr. Richard A. To be supplemented<br />

Spector<br />

154. Exhibits from the deposition of Dr. To be supplemented<br />

Richard A. Spector<br />

155. Any supplemental Affidavits or Reliance To be supplemented<br />

Material by Plaintiff’s or Defendants’<br />

Experts<br />

156. Any deposition testimony provided by To be supplemented<br />

any and all plaintiff and/or deposition<br />

fact and/or expert witness in this matter.<br />

157. Any and all demonstrative evidence to To be supplemented<br />

be developed and/or utilized by<br />

Plaintiff’s experts at trial<br />

158. Any additional exhibits identified at To be supplemented<br />

deposition of any expert or fact witness<br />

in this matter.<br />

Any document to be identified by<br />

Plaintiff in the ongoing discovery and<br />

deposition process<br />

To be supplemented<br />

46


All Photographs taken by Plaintiff or<br />

Plaintiff’s Experts<br />

Any Plaintiff supplementation of any<br />

report and supplementing documents<br />

which may occur<br />

Any and all Plaintiff demonstrative aids<br />

for trial to be exchanged at the<br />

appropriate time<br />

Testing<br />

Database<br />

159. Formaldehyde Testing Database<br />

Testing<br />

Documents<br />

prepared by the PSC<br />

Bill Scott Testing Data, October, 2008<br />

Bill Scott Testing Data, August, 2009<br />

Mold Testing Data<br />

Plaintiff’s Testing Protocol<br />

All Testing Results Produced Relating to<br />

Lyndon Wright Unit<br />

Inspection in<br />

Melville, LA<br />

160. Photographs taken by<br />

Plaintiffs/Plaintiff’s Experts during<br />

destructive testing at FEMA<br />

Staging/Storing Facility in Melville,<br />

Louisiana.<br />

161. Video taken by Plaintiff/Plaintiff’s<br />

Experts during the destructive testing at<br />

FEMA Staging/Storage Facility in<br />

Melville, Louisiana.<br />

162. Photographs taken by<br />

Defendants/Defendants’ Experts during<br />

destructive testing.<br />

163. Video taken by Defendants/Defendants’<br />

Experts during destructive testing.<br />

164. Animations created by C4 Animation<br />

(Reagan Johnson)<br />

166. Results of all testing and inspection of<br />

the Forest River/Wright unit including,<br />

but <strong>no</strong>t limited to, air sampling,<br />

temperature, humidity, and photographs<br />

thereof<br />

47<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

168. Test Results of mold sampling To be supplemented


performed by WD Scott Group during<br />

destructive testing.<br />

169. Test Results of mold sampling taken by<br />

Defendants’ Experts during destructive<br />

testing.<br />

171. Exemplar of a Personal Monitoring<br />

System for Aldehydes (Exemplar<br />

Passive Dosimeter)<br />

172. Exemplars of Various Component Wood<br />

Products from Lyndon Wright Forest<br />

River Travel Trailer.<br />

173. Exemplars of Alternative Wood<br />

Products from Lyndon Wright Forest<br />

River Travel Trailer.<br />

174. All additional measurements to<br />

measurements and graphic<br />

representations of Lyndon Wright <strong>trailer</strong><br />

to be identified<br />

Forest River,<br />

Inc.<br />

175. Forest River, Inc., Lyndon Wright <strong>trailer</strong><br />

unit file<br />

176. Any and all Class certification Forest<br />

River deposition testimony<br />

177. Any and all Class certification Forest<br />

River deposition exhibits / documents<br />

produced<br />

48<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

FR-0151924<br />

FR-151946<br />

To be supplemented<br />

To be supplemented<br />

178. Forest River Owner’s Manual FOREST 0002399-<br />

FOREST 0002483<br />

Forest River Draft Testing Protocol<br />

FR-LTW-EXP06-06698-<br />

FR-LTW-EXP06-006701<br />

179. FEMA Specifications FOREST 0003284-<br />

FOREST 0003289<br />

180. NACS Correspondence and Solicitation FOREST 0002503-<br />

and emails<br />

FOREST 0002508;<br />

181. Any and all Internal emails and<br />

communications relevant to FEMA<br />

production<br />

Liberty Building Emails<br />

FOREST 0003521<br />

To be supplemented<br />

FR-LTW-EXP06-<br />

019602;<br />

FR-LTW-EXP06-<br />

019676-<br />

FR-LTW-EXP06-


Email between John Odom and Don<br />

Snell 10/22/09 (Exhibit 20 of Liberty<br />

Deposition)<br />

ANSI/ASHRAE Standard 62.2-2004, pp.<br />

9-10<br />

49<br />

019678;<br />

FR-LTW-EXP06-<br />

019631-<br />

FR-LTW-EXP06-<br />

019634;<br />

FR-LTW-EXP06-<br />

019688-<br />

FR-LTW-EXP06-<br />

019698;<br />

FR-LTW-EXP06-<br />

019648-<br />

FR-LTW-EXP06-<br />

019653;<br />

FR-LTW-EXP06-<br />

019637-<br />

FR-LTW-EXP06-<br />

019644;<br />

FR-LTW-EXP06-<br />

019609-<br />

FR-LTW-EXP06-<br />

019616;<br />

FR-LTW-EXP06-<br />

019603-<br />

FR-LTW-EXP06-019608<br />

To be supplemented<br />

FR-LTW-EXP06-<br />

006498-<br />

FR-LTW-EXP06-006499<br />

To be supplemented<br />

182. Any and all Deposition Testimony of<br />

Elton Kiefer<br />

183. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Elton Kiefer<br />

184. Any and all Deposition Testimony of To be supplemented<br />

Jeff Burrian<br />

185. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Jeff Burrian<br />

186. Affidavits of Norman Nelson To be supplemented<br />

187. Curriculum Vitae of Norman Nelson FR-LTW-EXP06-<br />

019726-<br />

188. Reliance Materials and File of Norman<br />

Nelson<br />

FR-LTW-EXP06-019729<br />

To be supplemented


189. Any and all Deposition Testimony of To be supplemented<br />

Norman Nelson<br />

190. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Norman Nelson<br />

191. Report of G. Graham Allan LTW-EXP01-000001-<br />

LTW-EXP01-000003<br />

192. Curriculum Vitae of G. Graham Allan LTW-EXP01-000004-<br />

LTW-EXP01-000036<br />

Fee Schedule of G. Graham Allen LTW-EXP01-000037<br />

List of Testimonies of G. Graham Allen LTW-EXP01-000038<br />

193. Reliance Materials and File of G. To be supplemented<br />

Graham Allan<br />

194. Any and all Deposition Testimony of G. To be supplemented<br />

Graham Allan<br />

195. Any and all Exhibits from the To be supplemented<br />

deposition(s) of G. Graham Allan<br />

196. Report of Philip Cole, M.D. FR-LTW-EXP02-<br />

000001-<br />

FR-LTW-EXP02-000020<br />

Report of Philip Cole, M.D.<br />

FR-LTW-EXP02-<br />

000041-<br />

FR-LTW-EXP02-000060<br />

197. Curriculum Vitae of Philip Cole, M.D. FR-LTW-EXP02-<br />

000021-<br />

FR-LTW-EXP02-000037<br />

List of Testimonies of Philip Cole, M.D. FR-LTW-EXP02-000038<br />

FR-LTW-EXP02-000040<br />

198. Reliance Materials and File of Philip To be supplemented<br />

Cole, M.D.<br />

199. Any and all Deposition Testimony of To be supplemented<br />

Philip Cole, M.D.<br />

200. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Philip Cole, M.D.<br />

201. Affidavits of Nathan T. Dorris To be supplemented<br />

202. Curriculum Vitae of Nathan T. Dorris FR-LTW-EXP03-<br />

000001-<br />

FR-LTW-EXP03-000015<br />

203. Reliance Materials and File of Nathan T. To be supplemented<br />

Dorris<br />

204. Any and all Deposition Testimony of To be supplemented<br />

Nathan T. Dorris<br />

205. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Nathan T. Dorris<br />

206. Report of William L. Dyson FR-LTW-EXP04-<br />

50


000001-<br />

FR-LTW-EXP04-000019<br />

207. Curriculum Vitae of William L. Dyson FR-LTW-EXP04-<br />

000020-<br />

FR-LTW-EXP04-000023<br />

Fee Schedule of William L. Dyson<br />

List of Testimonies of Williams L.<br />

Dyson<br />

208. Reliance Materials and File of William<br />

L. Dyson<br />

51<br />

FR-LTW-EXP04-000024<br />

FR-LTW-EXP04-<br />

000025-<br />

FR-LTW-EXP04-000031<br />

FR-LTW-EXP04-<br />

000001-<br />

FR-LTW-EXP04-000567<br />

209. Any and all Deposition Testimony of To be supplemented<br />

William L. Dyson<br />

210. Any and all Exhibits from the To be supplemented<br />

deposition(s) of William L. Dyson<br />

211. Report of Thomas Fribley FR-LTW-EXP05-<br />

000001-<br />

FR-LTW-EXP05-000003<br />

212. Curriculum Vitae of Thomas Fribley FR-LTW-EXP05-<br />

000004-<br />

FR-LTW-EXP05-000008<br />

213. Reliance Materials and File of Thomas<br />

Fribley<br />

FR-LTW-EXP05-<br />

000001-<br />

FR-LTW-EXP05-001454<br />

214. Any and all Deposition Testimony of To be supplemented<br />

Thomas Fribley<br />

215. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Thomas Fribley<br />

216. Affidavits of Don Snell To be supplemented<br />

217. Curriculum Vitae of Don Snell FR-LTW-EXP06-<br />

019731-<br />

FR-LTW-EXP06-019735<br />

218. Reliance Materials and File of Don Snell To be supplemented<br />

219. Any and all Deposition Testimony of To be supplemented<br />

Don Snell<br />

220. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Don Snell<br />

221. Affidavits of Kenneth B. Smith To be supplemented<br />

222. Curriculum Vitae of Kenneth B. Smith LTW-EXP07-000001-<br />

LTW-EXP07-000002<br />

Fee Schedule of Kenneth B. Smith LTW-EXP07-000003-<br />

LTW-EXP07-000004<br />

223. Reliance Materials and File of Kenneth LTW-EXP07-000001-


B. Smith LTW-EXP07-000291<br />

224. Any and all Deposition Testimony of To be supplemented<br />

Kenneth B. Smith<br />

225. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Kenneth B. Smith<br />

226. Report of Dr. John W. Thompson FR-LTW-EXP08-<br />

000001-<br />

FR-LTW-EXP08-000015<br />

227. Curriculum Vitae of Dr. John W.<br />

Thompson<br />

FR-LTW-EXP08-<br />

000016-<br />

List of Testimonies of Dr. John W.<br />

Thompson<br />

Fee Schedule of Dr. John W. Thompson<br />

228. Reliance Materials and File of Dr. John<br />

W. Thompson<br />

52<br />

FR-LTW-EXP08-000037<br />

FR-LTW-EXP08-<br />

000038-<br />

FR-LTW-EXP08-000052<br />

FR-LTW-EXP08-000053<br />

FR-LTW-EXP08-<br />

000001-<br />

FR-LTW-EXP08-002293<br />

229. Any and all Deposition Testimony of Dr. To be supplemented<br />

John W. Thompson<br />

230. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Dr. John W. Thompson<br />

231. Affidavits of Tony Watson To be supplemented<br />

232. Curriculum Vitae of Tony Watson FR-LTW-EXP09-<br />

000169-<br />

FR-LTW-EXP09-000170<br />

FR-LTW-EXP09-000171<br />

List of Trial Testimonies of Tony<br />

Watson<br />

233. Reliance Materials and File of Tony To be supplemented<br />

Watson<br />

234. Any and all Deposition Testimony of To be supplemented<br />

Tony Watson<br />

235. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Tony Watson<br />

236. Affidavits of H. James Wedner, M.D. Bates Range to be<br />

supplied upon receipt of<br />

same<br />

237. Curriculum Vitae of H. James Wedner,<br />

M.D.<br />

238. Reliance Materials and File of H. James<br />

Wedner, M.D.<br />

Bates Range to be<br />

supplied upon receipt of<br />

same<br />

Bates Range to be<br />

supplied upon receipt of<br />

same<br />

239. Any and all Deposition Testimony of H. To be supplemented


James Wedner, M.D.<br />

240. Any and all Exhibits from the To be supplemented<br />

deposition(s) of H. James Wedner, M.D.<br />

241. Any and all Deposition Testimony of To be supplemented<br />

Jaime Albrecht<br />

242. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Jaime Albrecht<br />

243. Any and all Deposition Testimony of To be supplemented<br />

Jim Foltz<br />

244. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Jim Foltz<br />

245. Any and all Deposition Testimony of To be supplemented<br />

Forest River Warranty Officer, yet to be<br />

designated<br />

246. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Forest River Warranty<br />

Deponent, yet to be designated<br />

247. Any and all Deposition Testimony of To be supplemented<br />

Corporate Representative of Forest<br />

River, Doug Gaeddert<br />

248. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Corporate<br />

Representative of Forest River, Doug<br />

Gaeddert<br />

249. Any and all Deposition Testimony of To be supplemented<br />

any and/or all Corporate Representative<br />

of Forest River, yet to be designated<br />

250. Any and all Exhibits from the To be supplemented<br />

deposition(s) of any and/or all Corporate<br />

Representative of Forest River, yet to be<br />

designated<br />

251. Any and all documentation identified by To be supplemented<br />

defendant’s experts in the preparation of<br />

their reports and/or testimony.<br />

252. Any and all exhibits identified and/or To be supplemented<br />

used and/or relied upon by defendant’s<br />

in the ongoing litigation of this matter.<br />

Pricing costs for 32 BHLE FOREST 0003171-<br />

FOREST 0003249<br />

32 BHLE Diagrams and Specs FOREST 0003250-<br />

FOREST 0003299;<br />

FOREST 0003366-<br />

FOREST 0003391<br />

Lippert 32 BHLE Diagrams FOREST 0003140;<br />

53


FOREST 0003344-<br />

FOREST 0003345;<br />

FOREST 0003351<br />

Any and all blueprints and design To be supplemented<br />

documents produced at deposition<br />

255. Internal Forest River Memorandum FOREST 0003294-<br />

regarding proposed production schedule FOREST 0003299<br />

256. September 1, 2005, NACS/FEMA To be supplemented<br />

Solicitation and Specifications<br />

257. Handwritten designs, drawings, and To be supplemented<br />

<strong>no</strong>tes for FEMA units<br />

258. NACS/Forest River FEMA To be supplemented<br />

Specifications documents<br />

259. 2004 Email from NACS to Forest River To be supplemented<br />

regarding FEMA Trailer Production<br />

Specifications<br />

260. November 2006 Elton Kiefer <strong>no</strong>tes To be supplemented<br />

regarding Patrick and Adorn switching<br />

to LFE in early 2007<br />

261. September 1, 2005 email Ty Miller to To be supplemented<br />

Doug Gaeddert and Tom Martin<br />

regarding California production<br />

Deposition Transcript of Brian Deckle, P. 79-81<br />

NACS<br />

Warranty Documents and Repair To be supplemented<br />

Documents<br />

MSDS’s FOREST 0002609-<br />

FOREST 0002619<br />

Congressional Statement of Pete Liegl To be supplemented<br />

September 1, 2005, Production FOREST 0003449<br />

Memorandum<br />

Forest River’s responses to Discovery To be supplemented<br />

Requests<br />

Forest River Inspection Protocol To be supplemented<br />

Forest River Testing Methodologies FR-LTW-EXP06-006696<br />

from Liberty (Operational Pressures)<br />

Forest River Testing Methodologies<br />

from Liberty (Testing Methodologies)<br />

FR-LTW-EXP06-<br />

003857-<br />

FR-LTW-EXP06-003862<br />

Forest River Periodic Maintenance Chart FR-LTW-EXP06-017924<br />

Liberty Handwritten <strong>no</strong>tes starting FR-LTW-EXP06-<br />

07/30/09<br />

004902-<br />

FR-LTW-EXP06-004920<br />

Liberty Schematics of Trailer<br />

FR-LTW-EXP06-<br />

54


Billing records of all Forest River<br />

Defense Experts<br />

All photographs taken by Forest River<br />

and/or Forest River’s Experts<br />

Any document to be identified by<br />

Defendant Forest River in the ongoing<br />

discovery and deposition process<br />

Any Forest River supplementation of<br />

any report and supplementing documents<br />

which may occur<br />

Any and all Forest River demonstrative<br />

aids for trial to be exchanged at the<br />

appropriate time<br />

U.S.A.<br />

262. U.S.A. / FEMA Disaster File for Bobbi<br />

Wright and/or Lyndon Wright<br />

55<br />

017166;<br />

FR-LTW-EXP06-<br />

017925-<br />

FR-LTW-EXP06-017931<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

FEMA 124-000001-<br />

FEMA 124-000078<br />

263. Affidavits of Robert James, Ph.D. To be supplemented<br />

264. Curriculum Vitae of Robert James, To be supplemented<br />

Ph.D.<br />

265. Reliance Materials and File of Robert To be supplemented<br />

James, Ph.D.<br />

266. Any and all Deposition Testimony of To be supplemented<br />

Robert James, Ph.D.<br />

267. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Robert James, Ph.D.<br />

268. Affidavits of Bruce Kelman, Ph.D. To be supplemented<br />

269. Curriculum Vitae of Bruce Kelman, To be supplemented<br />

Ph.D.<br />

270. Reliance Materials and File of Bruce To be supplemented<br />

Kelman, Ph.D.<br />

271. Any and all Deposition Testimony of To be supplemented<br />

Bruce Kelman, Ph.D.<br />

272. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Bruce Kelman, Ph.D.<br />

273. Affidavits of Michael Lindell, Ph.D. To be supplemented<br />

274. Curriculum Vitae of Michael Lindell, To be supplemented<br />

Ph. D.<br />

275. Reliance Materials and File of Michael To be supplemented<br />

Lindell, Ph.D.<br />

276. Any and all Deposition Testimony of To be supplemented


Michael Lindell, Ph.D.<br />

277. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Michael Lindell, Ph.D.<br />

278. Affidavits of Richard Monson, M.D., To be supplemented<br />

Sc.D.<br />

279. Curriculum Vitae of Richard Monson, To be supplemented<br />

M.D., Sc.D.<br />

280. Reliance Materials and File of Richard To be supplemented<br />

Monson, M.D., Sc.D.<br />

281. Any and all Deposition Testimony of To be supplemented<br />

Richard Monson, M.D., Sc.D.<br />

282. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Richard Monson, M.D.,<br />

Sc.D.<br />

283. Affidavits of Mark Polk To be supplemented<br />

284. Curriculum Vitae of Mark Polk To be supplemented<br />

285. Reliance Materials and File of Mark To be supplemented<br />

Polk<br />

286. Any and all Deposition Testimony of To be supplemented<br />

Mark Polk<br />

287. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Mark Polk<br />

288. Affidavits of Coreen Robbins, M.H.S., To be supplemented<br />

Ph.D., C.I.H.<br />

289. Curriculum Vitae of Coreen Robbins, To be supplemented<br />

M.H.S., Ph.D., C.I.H.<br />

290. Reliance Materials and File of Coreen To be supplemented<br />

Robbins, M.H.S., Ph.D., C.I.H.<br />

291. Any and all Deposition Testimony of To be supplemented<br />

Coreen Robbins, M.H.S., Ph.D., C.I.H.<br />

292. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Coreen Robbins,<br />

M.H.S., Ph.D., C.I.H.<br />

293. Any and all Deposition Testimony of Dr. To be supplemented<br />

Christopher DeRosa<br />

294. Any and all Exhibits from the To be supplemented<br />

deposition(s) of Dr. Christopher DeRosa<br />

295. FEMA Storage Site<br />

To be supplemented<br />

Duties/Responsibilities regarding Forest<br />

River, Inc.<br />

296. FEMA Model Travel Trailer<br />

To be supplemented<br />

Procurement Specifications dated 08-12-<br />

2004 (HSFE04-04-Q-800)<br />

297. FEMA Accessible Model Travel Trailer To be supplemented<br />

56


Procurement Specifications dated 04-21-<br />

2006 (with Accessible One Bedroom<br />

Travel Trailer Floor plan)<br />

298. “Important Information for Travel<br />

Trailer Occupants” FEMA brochure<br />

299. FEMA Model Travel Trailer<br />

Procurement Specifications Dated: July<br />

14, 2005<br />

300. Declaration of Kevin Souza, former<br />

Acting Deputy Director of Individual<br />

Assistance Division of FEMA<br />

301. “FEMA Storage Site<br />

Duties/Responsibilities”<br />

302. April 25, 2008 letter from FEMA to a<br />

THU occupant<br />

303. Summary of Test Results conducted by<br />

Weston Solutions, Inc. for the U.S. EPA<br />

304. Air Toxics, Ltd. Laboratory Narrative<br />

for samples submitted by Weston<br />

Solutions<br />

305. FEMA test results for <strong>formaldehyde</strong><br />

testing at FEMA THU staging areas<br />

during November 2005, December 2005,<br />

and January 2006<br />

306. FEMA Memorandum from May 31,<br />

2006 regarding Formaldehyde Air<br />

Sampling at the THU staging area in<br />

Purvis, Mississippi<br />

307. Email correspondence between FEMA<br />

and Government staff<br />

57<br />

PSC002350 –<br />

PSC002351<br />

PSC003049 –<br />

PSC003057<br />

PSC003058 –<br />

PSC003065<br />

PSC003092 –<br />

PSC003094<br />

PSC003397 –<br />

PSC003399<br />

PSC003407 –<br />

PSC003409<br />

PSC003410 –<br />

PSC003415<br />

PSC003416 –<br />

PSC003420<br />

PSC003421 –<br />

PSC003438<br />

PSC003439 –<br />

PSC003447<br />

308. FEMA Job Hazard Analysis Worksheet PSC023600<br />

309. FEMA Model Travel Trailer<br />

Procurement Specifications dated<br />

August 12, 2004<br />

310. New FEMA Procurement Specifications<br />

dated April 11, 2008 Release Number<br />

HQ-08-056<br />

311. FEMA Formaldehyde Timeline as of<br />

June 15, 2007<br />

312. FEMA Timeline as of August 7, 2008<br />

(From the deposition of Kevin Souza,<br />

FEMA Representative)<br />

313. FEMA Procedure Storage Site Manual<br />

Fall 2005<br />

FOREST-0002503 –<br />

FOREST-0002508<br />

PSC023601 –<br />

PSC023686<br />

PSC023687 –<br />

PSC023689<br />

PSC023690 –<br />

PSC023702<br />

To be supplemented


314. Dept of Homeland Security-Office of<br />

Inspector General-Hurricane Katrina<br />

Temporary Housing Technical<br />

Assistance Contracts- August 20, 2008<br />

(Internal Audit: OIG-08-88)<br />

315. FEMA Myths & Facts: Travel Trailers-<br />

November 8, 2007<br />

316. FEMA media release: Katrina/Rita<br />

Housing Facts-January 29, 2008<br />

317. FEMA media release: FEMA’s Ongoing<br />

Response to Formaldehyde-February 12,<br />

2008<br />

318. FEMA media release: CDC Results of<br />

Formaldehyde Level Tests- February 14,<br />

2008<br />

319. FEMA media release: FEMA Plan of<br />

Action on Formaldehyde Findings to be<br />

Implemented Immediately-February 14,<br />

2008<br />

320. FEMA media release: FEMA Offering<br />

Formaldehyde Testing to Occupants of<br />

Trailers and Mobile Homes in Disasters<br />

Nationwide-February 22, 2008<br />

321. FEMA media release: FAQ: 2008<br />

Disaster Housing Plan – June 10, 2008<br />

322. FEMA Statement on Formaldehyde –<br />

July 9, 2008<br />

323. FEMA media release: Myths & Facts<br />

about FEMA Housing Following<br />

Katrina-May 26, 2008<br />

324. FEMA media release: New Task<br />

Contract Awarded for Temporary<br />

Housing Units-August 4, 2008<br />

325. FEMA media release: Frequently Asked<br />

Questions-October 27, 2008<br />

326. FEMA media release: Initial Indoor Air<br />

Quality Tests Results-November 14,<br />

2008<br />

327. FEMA media release: FAQ National<br />

Disaster Housing Strategy – January 16,<br />

2009<br />

328. FEMA Statement on Travel Trailers and<br />

Formaldehyde<br />

58<br />

PSC023835 –<br />

PSC023863<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

PSC023795<br />

329. Email from Christopher DeRosa to PSC023796


Howard Frumkin on February 27, 2007<br />

330. Correspondence from Christopher<br />

DeRosa to Patrick Preston on February<br />

27, 2007<br />

331. Email from Christopher DeRosa to<br />

Howard Frumkin and Thomas Sinks on<br />

March 9, 2007<br />

332. Email from Christopher DeRosa to Mike<br />

Groutt on August 10, 2007<br />

333. Comments on Chro<strong>no</strong>logy of FEMA<br />

Trailers, drafted by Christopher DeRosa<br />

334. Correspondence from Christopher<br />

DeRosa to Howard Frumkin on<br />

September 21, 2007<br />

335. Email from Thomas Sinks to All CDC<br />

on October 12, 2007<br />

336. NCEH/ATSDR Procedures regarding<br />

Official Interaction with Persons or<br />

organization outside of NCEH/ATSDR<br />

59<br />

PSC023797<br />

PSC023798 –<br />

PSC023799<br />

PSC023800<br />

PSC023801<br />

PSC023802 –<br />

PSC023808<br />

PSC023809<br />

PSC023810 –<br />

PSC023811<br />

337. Logbook of Joseph Little To be supplemented<br />

338. Email from Patrick Preston to Scott To be supplemented<br />

Wright on November 30, 2005<br />

339. Email from Scott Wright and Joseph<br />

Little to Richard Nikel, et al., on<br />

December 7, 2006<br />

To be supplemented<br />

340. Correspondence between Barbara<br />

Rogers to Angela Davis and Sascha<br />

Fielding on March 21, 2007<br />

341. Email of Mary Margaret Walker<br />

(FEMA-WAXMAN-7-26-07 Production<br />

– 485)<br />

342. Correspondence From Mark Keim to<br />

Patrick Preston on March 17, 2007<br />

343. Correspondence from Patrick Preston to<br />

Scott Wright on November 30, 2005<br />

344. Email between Sam Coleman, Joseph<br />

Little and Scott Wright on December 1,<br />

2006<br />

345. Correspondence from Mark Keim to<br />

Patrick Preston on February 1, 2007<br />

346. Email to and from Philip Allred on<br />

February 15, 2007<br />

347. Email from Anne Sowell to Mark<br />

Bashor on August 8, 2007<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

PSC023819 –<br />

PSC023821<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented


348. Email between Patrick Preston and To be supplemented<br />

Margaret Ramos on February 27, 2007<br />

349. Email between David Chawaga and To be supplemented<br />

Mary Margaret Walker on May 1, 2007<br />

350. FEMA: Interim Direction on use of<br />

Temporary Housing Units (Revision<br />

PSC023828 –<br />

PSC023834<br />

Effective Date: March 10, 2008)<br />

. FEMA: FEMA Begins Next Phase of To be supplemented<br />

Inventory Reduction of Excess<br />

Temporary Housing Units<br />

352. “FEMA: Important Formaldehyde FEMA09-000388<br />

Information from FEMA Housing<br />

Occupants:<br />

353. “FEMA Travel Trailer Requirements” PSC0261671<br />

354. Any and all documents produced by Dr. To be supplemented<br />

Christopher DeRosa at his deposition,<br />

which will be taken/has been taken, or<br />

used as exhibits thereto<br />

355. Flyer: “CDC will test Trailers and To be supplemented<br />

Mobile Homes for Formaldehyde for<br />

CDC Partners such as Community<br />

Organizations in Louisiana and<br />

Mississippi” dated December 2007<br />

356. Script for Formaldehyde Concerns in To be supplemented<br />

Temporary Housing Unit: IA recipients<br />

with questions about <strong>formaldehyde</strong>, July<br />

2007<br />

357. Applicants Reporting MH/TT<br />

To be supplemented<br />

Formaldehyde Issues: IA recipients with<br />

questions about <strong>formaldehyde</strong>, July 2007<br />

358. Lottie Travel Trailer (Receiving) To be supplemented<br />

Inspection Checklist<br />

359. FEMA Brochure: “Important<br />

To be supplemented<br />

Information for Travel Trailer<br />

Occupants”<br />

360. FEMA: Important Formaldehyde To be supplemented<br />

Information for FEMA Housing<br />

Occupants<br />

361. Email from Martin McNeese dated To be supplemented<br />

October 11, 2006<br />

362. Email from Curtis Melnick dated May To be supplemented<br />

11, 2006<br />

363. Memo from FEMA Temporary Housing<br />

Agent Group: Occupants with questions<br />

To be supplemented<br />

60


about Formaldehyde regarding<br />

Formaldehyde-Help-line Calls, Referrals<br />

and Transfers dated July 2007<br />

364. FEMA Internal documents regarding<br />

<strong>formaldehyde</strong><br />

365. Emails regarding Katrina and Rita<br />

housing estimates dated November 1,<br />

2005<br />

366. Assessment of health Complaints among<br />

Pediatric Residents of FEMA-Supplied<br />

Trailers and Mobile Homes in Hancock<br />

County, Mississippi (Exhibit from the<br />

deposition of Michael Lapinski)<br />

367. Fact Sheet: Assessment of Health<br />

Complaints Among Children Living in<br />

FEMA Temporary Housing Units in<br />

Hancock county, Mississippi (Exhibit<br />

from the deposition of Michael<br />

Lapinski)<br />

Emails re: Formaldehyde<br />

Formaldehyde Flyer<br />

61<br />

To be supplemented<br />

To be supplemented<br />

Lapinski<br />

Exhibit 17<br />

Lapinski<br />

Exhibit 16<br />

To be supplemented<br />

To be supplemented<br />

Request for Proposal re: Travel Trailers FR 3522<br />

To be supplemented<br />

368. Any and all documentation and/or<br />

exhibits identified by defendant’s<br />

experts and/or fact witness in the<br />

preparation of their reports and/or<br />

testimony.<br />

369. Any and all exhibits identified and/or<br />

used and/or relied upon by defendant’s<br />

in the ongoing litigation of this matter.<br />

Shaw<br />

Billing records of all <strong>US</strong>A / FEMA<br />

Defense Experts<br />

Any photographs taken by <strong>US</strong>A / FEMA<br />

and/or <strong>US</strong>A / FEMA defense experts<br />

Any document to be identified by<br />

Defendant <strong>US</strong>A / FEMA in the ongoing<br />

discovery and deposition process<br />

Any <strong>US</strong>A / FEMA supplementation of<br />

any report and supplementing documents<br />

which may occur<br />

Any and all <strong>US</strong>A / FEMA demonstrative<br />

aids for trial to be exchanged at the<br />

appropriate time<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented


Environmen<br />

tal<br />

370. Any and all Class certification Shaw<br />

Environmental deposition testimony<br />

371. Any and all Class certification Shaw<br />

Environmental deposition exhibits /<br />

documents produced<br />

372. Shaw Environmental unit file on Lyndon<br />

Wright <strong>trailer</strong><br />

62<br />

To be supplemented<br />

To be supplemented<br />

SHAW WRI-00001-<br />

SHAW WRI-00017<br />

Entergy Orleans Meter Data SHAW-WRI 00051<br />

Shaw Standard Operating Procedure<br />

Trailer Processing and Yard Inspection<br />

dated 2/1/06<br />

SHAW 013564-<br />

SHAW 013568<br />

CH2M Hill, Inc., FEMA Trailer User’s SHAW 013523-<br />

Guide<br />

SHAW 013538<br />

373. Shaw / FEMA contract To be supplemented<br />

IA / TAC Contract SHAW 001890-<br />

SHAW 002019<br />

FEMA Request for Proposal Contract SHAW 000373<br />

HSFEHQ-05-0573<br />

SHAW 000578<br />

Checklists / PMI form SHAW 013303<br />

Picture of Installed Trailer SHAW 002517<br />

TT/MH QC Construction Issues/Maint SHAW 002363-<br />

Issues Sheet<br />

SHAW 002364<br />

Shaw Code emails and communications To be supplemented<br />

Orleans Parish Motion SHAW 002099-<br />

SHAW 003912<br />

Kenner Ordinance SHAW 003932-<br />

SHAW 003934<br />

Gretna & Westwego Ordinance SHAW 003930-<br />

SHAW 003931<br />

Communications with Subs re:<br />

implementation of Emergency Housing<br />

Contract (to be identified)<br />

C. Martin Documents (and other transfer<br />

documents)<br />

To be supplemented<br />

SHAW 000042-<br />

SHAW 000051;<br />

LW-CMC-000001-<br />

LW-CMC-000071<br />

Crown Roofing Services Documents CROWN 000001-<br />

CROWN 000016<br />

July 19, 2006 Work Plan SHAW 000669-<br />

SHAW 000700<br />

Pier Construction SHAW 002416<br />

Shaw Emails relating to Formaldehyde SHAW 013510;


SHAW 013511-<br />

SHAW 013512;<br />

SHAW 013513-<br />

SHAW 013514;<br />

SHAW 013515-<br />

SHAW013516;<br />

SHAW 013517-<br />

SHAW 013518;<br />

SHAW 013519-<br />

SHAW 013520;<br />

SHAW 013521-<br />

SHAW 013522;<br />

SHAW 013539-<br />

SHAW 013545;<br />

SHAW 013546-<br />

SHAW 013547;<br />

SHAW 013548-<br />

SHAW 013549;<br />

SHAW 013554;<br />

SHAW 013555-<br />

SHAW 013556;<br />

SHAW 013557;<br />

SHAW 013558-<br />

SHAW 013559;<br />

SHAW 013560-<br />

SHAW 013562<br />

Shaw Email: Burgess to Goetz, SHAW 002257-<br />

10/18/05<br />

SHAW 002259<br />

9:51 a.m.<br />

Shaw Email: Burgess to Goetz, 10/18/05<br />

2:48 p.m.<br />

SHAW 002260-<br />

SHAW 002263<br />

Shaw Email: Miller to Burgess, 11/29/05 SHAW 003145-<br />

SHAW 003147<br />

Shaw Email: Miller to Burgess, 11/22/05 SHAW 003058<br />

Shaw Email: Black to Janz, 11/11/05 SHAW 002773-<br />

SHAW 002796<br />

Shaw Email: Neal to Janz, 02/03/06 SHAW 005015-<br />

SHAW 005016<br />

Shaw Email: Orris to Brixius, 10/19/05 SHAW 002302-<br />

SHAW 002303<br />

Shaw Email: Janz to Smiley, 07/06/06 SHAW 011024-<br />

SHAW 011025<br />

Shaw Policies and Clarifications SHAW 002726-<br />

SHAW 002727<br />

63


Shaw Group Suggested Call Center<br />

Questionnaire<br />

SHAW 013236-<br />

SHAW 013237<br />

Haul & Install Call Center Questionnaire SHAW 013238-<br />

SHAW 013240<br />

Do Not Lease Document SHAW 003267<br />

Shaw Task Order 05-0006 Site SHAW 000601-<br />

Identification<br />

SHAW 000615<br />

Shaw Task Order No. 014 Trailer<br />

Transportation<br />

SHAW 000631-<br />

SHAW 000632<br />

Final Draft Work Order, March 19, 2006 SHAW 000900-<br />

SHAW 000939<br />

Final Group Site Work Plan, April 2006 SHAW 000952-<br />

SHAW 000992<br />

June 8, 2006, Work Plan SHAW 000746-<br />

SHAW 000786<br />

June 14, 2006 City Park Trailer Park SHAW 001054-<br />

SHAW 001089<br />

Final Work Order on Group Sites, June<br />

26, 2006<br />

SHAW 001102-<br />

SHAW 001142<br />

Shaw Inspection Protocol (2 pages) To be supplemented<br />

Demobilization Documents SHAW 002316-<br />

SHAW 002317<br />

374. All FEMA task orders to Shaw To be supplemented<br />

Environmental<br />

375. All FEMA extension of time orders to To be supplemented<br />

Shaw Environmental<br />

All <strong>formaldehyde</strong> emails and documents To be supplemented<br />

RCG Contract Documents<br />

376. All FEMA Amendments or<br />

Modifications to Shaw Environmental<br />

contract<br />

64<br />

To be supplemented<br />

To be supplemented<br />

377. All Shaw Environmental work plans To be supplemented<br />

produced to Plaintiff<br />

378. Subcontractor agreement with installer To be supplemented<br />

of Wright unit<br />

379. Affidavits of John D. Osteraas To be supplemented<br />

380. Curriculum Vitae of John D. Osteraas To be supplemented<br />

381. Reliance Materials and File of John D. To be supplemented<br />

Osteraas<br />

382. Any and all Deposition Testimony of To be supplemented<br />

John D. Osteraas<br />

383. Any and all Exhibits from the To be supplemented<br />

deposition(s) of John D. Osteraas<br />

384. Any and all Deposition Testimony of To be supplemented


Corporate Representative of Shaw<br />

Environmental, yet to be designated<br />

385. Any and all Exhibits from the<br />

deposition(s) of Corporate<br />

Representative of Shaw Environmental,<br />

yet to be designated<br />

386. Any and all Deposition Testimony of<br />

Project Manager of Shaw<br />

Environmental, yet to be designated<br />

387. Any and all Exhibits from the<br />

deposition(s) of Project Manager of<br />

Shaw Environmental, yet to be<br />

designated<br />

388. Any and all additional documents <strong>no</strong>t yet<br />

produced in this matter<br />

389. Any and all documentation and/or<br />

exhibits identified by defendant’s<br />

experts and/or fact witness in the<br />

preparation of their reports and/or<br />

testimony.<br />

390. Any and all exhibits identified and/or<br />

used and/or relied upon by defendant’s<br />

in the ongoing litigation of this matter.<br />

Billing records of all Shaw<br />

Environmental Defense Experts<br />

Any photographs taken by Shaw<br />

Environmental and/or Shaw<br />

Environmental defense experts<br />

Any Shaw Environmental<br />

supplementation of any report and<br />

supplementing documents which may<br />

occur<br />

Any document to be identified by<br />

Defendant Shaw Environmental in the<br />

ongoing discovery and deposition<br />

process<br />

Any and all Shaw Environmental<br />

demonstrative aids for trial to be<br />

exchanged at the appropriate time<br />

Wright Unit<br />

391. Photographs taken by or in the<br />

possession of Wright of the Forest River,<br />

Inc., unit<br />

Photographs of Lyndon Wright with<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

65


Trailer<br />

392. Any and all labels or stickers on the<br />

Forest River, Inc., unit occupied by<br />

Lyndon Wright<br />

Billing records of all Shaw<br />

Environmental Defense Experts<br />

All photographs taken by Shaw<br />

Environmental<br />

Wright File<br />

393. Photographs of Lyndon Wright<br />

regarding skin conditions<br />

66<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

394. Lyndon Wright Financial Records To be supplemented<br />

395. Lyndon Wright Employment Records To be supplemented<br />

Employment Records from the City of<br />

New Orleans related to Lyndon Wright<br />

LW-CITY NO00001-<br />

00256<br />

Attendance Records from City of New<br />

Orleans and Hyatt New Orleans relating<br />

to Lyndon Wright<br />

LW-CITY NO 00001-<br />

00256 & LW-<br />

HYATT00001-00126<br />

Lyndon Wright Original Complaint<br />

Lyndon Wright Amended Complaint<br />

Lyndon Wright Plaintiff Fact Sheet<br />

Lyndon Wright Amended Plaintiff Fact<br />

Sheet<br />

Medical<br />

Records<br />

396. Medical Records from Dr. Farber,<br />

Kenner Dermatology / Gulf South<br />

Medical and Surgical Institute regarding<br />

Lyndon Wright<br />

Photographs of Lyndon Wright from the<br />

records of Kenner Dermatology<br />

Medical Records from East Jefferson<br />

General Hospital regarding Lyndon<br />

Wright<br />

397. Medical Records from Dr. Worley<br />

regarding Lyndon Wright<br />

398. Medical Records from Uptown<br />

Nephrology regarding Lyndon Wright<br />

399. Medical Records from Dr. Richard<br />

Spector regarding Lyndon Wright<br />

Medical Records from Dr. Kenneth<br />

Smith regarding Lyndon Wright<br />

Medical Records of Dr. H. James<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

LWFR-EXP2-000021-<br />

LWFR-EXP2-000052<br />

LWFR-EXP2-000010-<br />

LWFR-EXP2-000020<br />

LWFR-EXP15-000518-<br />

LWFR-EXP15-000522;<br />

LW-EJGH0001-<br />

LW-EJGH00041<br />

LWFR-EXP14-000255-<br />

LWFR-EXP14-000256<br />

LWFW-EXP14-000085-<br />

LWFW-EXP14-000254<br />

LWFR-EXP14-000008-<br />

LWFR-EXP14-000084<br />

LTW-EXP07-000250<br />

LTW-EXP07-000291<br />

To be supplemented


Wedner<br />

Touro Medical Records<br />

Dr. Shwery administered psychological<br />

testing data<br />

Dr. Thompson / Dr. Mangu<strong>no</strong>-Mire<br />

psychological testing<br />

Report of Gina Mangu<strong>no</strong>-Mire<br />

400. Rite Aid Pharmacy Records regarding<br />

Lyndon Wright<br />

Walgreens Pharmacy Records regarding<br />

Lyndon Wright<br />

Others<br />

Demonstrative wood panels removed<br />

from the Lyndon Wright Trailer<br />

Demonstrative Samples of No<br />

Formaldehyde Added wood composite<br />

products<br />

401. Any and all Deposition Testimony of<br />

Representative of NACS, yet to be<br />

designated<br />

402. Any and all Exhibits from the<br />

deposition(s) of Representative of<br />

NACS, yet to be designated<br />

403. Any and all Deposition Testimony of<br />

Representative of RVIA, yet to be<br />

designated<br />

404. Any and all Exhibits from the<br />

deposition(s) of Representative of<br />

RVIA, yet to be designated<br />

Any and all Deposition Testimony of<br />

Representative of Lippert Components,<br />

yet to be designated<br />

Any and all Exhibits from the<br />

deposition(s) of Representative of<br />

LWFR-EXP12-000040-<br />

LWFR-EXP12-000046;<br />

LWFR-EXP12-000150-<br />

LWFR-EXP12-000153<br />

LWFR-EXP12-000289-<br />

LWFR-EXP12-000312;<br />

LWFR-EXP12-000512-<br />

LWFR-EXP12-000519<br />

FR-LTW-EXP08-<br />

002224-<br />

FR-LTW-EXP08-002258<br />

To be supplemented<br />

FR-LTW-EXP08-<br />

002259-<br />

FR-LTW-EXP08-002261<br />

LWFR-EXP12-000279-<br />

LWFR-EXP12-000286<br />

LWFR-EXP12-000485-<br />

LWFR-EXP12-000509<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

67


Lippert Components, yet to be<br />

designated<br />

Any and all Deposition Testimony of<br />

Representative of RCG Enterprises, yet<br />

to be designated<br />

Any and all Exhibits from the<br />

deposition(s) of Representative of RCG<br />

Enterprises, yet to be designated<br />

Louisiana State Board of Medical<br />

Examiners Temporary Permit<br />

Qualifications/Instructions<br />

BlueLinx Corporation: Material Safety<br />

Data Sheet for urea Formaldehyde<br />

Bonded Wood Products<br />

Georgia-Pacific: Material Safety Data<br />

Sheet for Urea Formaldehyde Bonded<br />

Wood Products<br />

Louisiana Pacific: Material Safety Data<br />

Sheet for Urea Formaldehyde Bonded<br />

Panel Products<br />

Lippert Component Frame Design for<br />

32BHLE units<br />

Georgia Pacific: Material Safety Data<br />

Sheet #30 for UF Bonded Wood<br />

Products<br />

Georgia Pacific: Material Safety Data<br />

Sheet #31 for Wood and Wood Products<br />

Manufactured Home Decking Labels<br />

from Georgia Pacific<br />

City of New Orleans Environmental<br />

testing results and report responsive to<br />

Forest River, Inc., subpoena<br />

Any photographs and/or videos taken by<br />

Scott Johnson of the Testing of the<br />

Forest River Unit<br />

Any and all documentation and/or<br />

exhibits identified by defendant’s<br />

experts and/or fact witness in the<br />

preparation of their reports and/or<br />

testimony.<br />

Any document necessary for rebuttal<br />

Any and all exhibits and/or documents<br />

identified and/or used and/or relied upon<br />

by defendant’s in the ongoing litigation<br />

To be supplemented<br />

To be supplemented<br />

PSC026167 –<br />

PSC026172<br />

PSC003068 –<br />

PSC003078<br />

PSC003079 –<br />

PSC003091<br />

FLE00006354<br />

To be supplemented<br />

GAPAC-000001 –<br />

GAPAC-000006<br />

GAPAC-000007 –<br />

GAPAC-000011<br />

GAPAC-000012 –<br />

GAPAC-000014<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

To be supplemented<br />

68


of this matter.<br />

Any and all deposition testimony and/or<br />

documents or exhibits introduced at any<br />

deposition of plaintiff’s and/or<br />

defendants’ experts<br />

Any and all plaintiff and/or defendants<br />

expert reports, both preliminary and<br />

final, submitted and anticipated to be<br />

submitted including all reliance<br />

materials.<br />

To be supplemented<br />

To be supplemented<br />

Plaintiff respectfully reserves the right to utilize any exhibit listed by any other party or<br />

utilized as an exhibit in the depositions taken in this matter. Plaintiff further respectfully<br />

reserves the right to supplement and amend this list once discovery is complete.<br />

CERTIFICATE OF SERVICE<br />

RESPECTFULLY SUBMITTED:<br />

FRANK J. D’AMICO, JR., APLC<br />

BY: s/Frank J. D’Amico, Jr.<br />

FRANK J. D’AMICO, JR., T.A. (#17519)<br />

AARON Z. AHLQUIST (#29063)<br />

FRANK J. D’AMICO, JR., APLC<br />

622 Baronne Street<br />

New Orleans, LA 70113<br />

Telephone: (504) 525-7272<br />

Fax: (504) 525-952<br />

I hereby certify that on January 12, 2010, I electronically filed the foregoing with the<br />

Clerk of <strong>Court</strong> by using the CM/ECF system which will send a <strong>no</strong>tice of electronic filing to all<br />

counsel of record who are CM/ECF participants. I further certify that I mailed the foregoing<br />

document and the <strong>no</strong>tice of electronic filing by first-class mail to all counsel of record who are<br />

<strong>no</strong>n-CM/ECF participants.<br />

s/Frank J. D’Amico<br />

FRANK J. D’AMICO, #17519<br />

69

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!